US20100256742A1 - Tapered Polymeric Stent And Method Of Fabricating Same - Google Patents
Tapered Polymeric Stent And Method Of Fabricating Same Download PDFInfo
- Publication number
- US20100256742A1 US20100256742A1 US12/816,275 US81627510A US2010256742A1 US 20100256742 A1 US20100256742 A1 US 20100256742A1 US 81627510 A US81627510 A US 81627510A US 2010256742 A1 US2010256742 A1 US 2010256742A1
- Authority
- US
- United States
- Prior art keywords
- tube
- segment
- stent
- cylindrical mold
- end segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
- B29C49/071—Preforms or parisons characterised by their configuration, e.g. geometry, dimensions or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/844—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
- B29C49/42—Component parts, details or accessories; Auxiliary operations
- B29C49/4273—Auxiliary operations after the blow-moulding operation not otherwise provided for
- B29C49/4278—Cutting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
- B29C49/42—Component parts, details or accessories; Auxiliary operations
- B29C49/48—Moulds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0067—Three-dimensional shapes conical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2793/00—Shaping techniques involving a cutting or machining operation
- B29C2793/009—Shaping techniques involving a cutting or machining operation after shaping
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2949/00—Indexing scheme relating to blow-moulding
- B29C2949/07—Preforms or parisons characterised by their configuration
- B29C2949/079—Auxiliary parts or inserts
- B29C2949/08—Preforms made of several individual parts, e.g. by welding or gluing parts together
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C49/00—Blow-moulding, i.e. blowing a preform or parison to a desired shape within a mould; Apparatus therefor
- B29C49/42—Component parts, details or accessories; Auxiliary operations
- B29C49/48—Moulds
- B29C49/54—Moulds for undercut articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
- B29K2067/04—Polyesters derived from hydroxycarboxylic acids
- B29K2067/046—PLA, i.e. polylactic acid or polylactide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0056—Biocompatible, e.g. biopolymers or bioelastomers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
- B29L2031/7534—Cardiovascular protheses
Definitions
- This invention relates to a method of fabricating a stent.
- This invention relates to radially expandable endoprostheses which are adapted to be implanted in a body lumen.
- An “endoprosthesis” corresponds to an artificial implantable medical device that is placed inside the body.
- a “lumen” refers to a cavity of a tubular organ such as a blood vessel.
- These endoprostheses are commonly referred to as stents.
- Stents are generally cylindrically shaped devices which function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels.
- Step refers to a narrowing or constriction of the diameter of a bodily passage or orifice.
- stents reinforce body vessels and prevent restenosis following angioplasty in the vascular system.
- Restenosis refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been treated (as by balloon angioplasty or valvuloplasty) with apparent success.
- the cylindrical structure of stents is typically composed of a scaffolding that includes a pattern or network of interconnecting structural elements or struts.
- the scaffolding can be formed from wires, tubes, or planar films of material rolled into a cylindrical shape.
- a medicated stent may be fabricated by coating the surface of either a metallic or polymeric scaffolding with a polymeric carrier.
- the polymeric carrier can include an active agent or drug.
- the pattern that makes up the stent allows the stent to be radially expandable and longitudinally flexible. Longitudinal flexibility facilitates delivery of the stent and radial rigidity is needed to hold open a body lumen.
- the pattern should be designed to maintain the necessary longitudinal flexibility and radial rigidity of the stent.
- a number of techniques have been suggested to fabricate stents from tubes and planar films or sheets.
- One such technique involves laser cutting or etching a pattern onto a material. Laser cutting may be performed on a planar film of a material which is then rolled into a tube. Alternatively, a desired pattern may be etched directly onto a tube. Fabricating a stent from a tube is preferable due to time and cost considerations.
- Other techniques involve cutting a desired pattern into a sheet or a tube via chemical etching or electrical discharge machining. Laser cutting of stents has been described in a number of publications including U.S. Pat. No. 5,780,807 to Saunders, U.S. Pat. No. 5,922,005 to Richter and U.S. Pat. No. 5,906,759 to Richter.
- a stent it is desirable for a stent to have certain mechanical properties to facilitate delivery and deployment of a stent, especially in the bending portions of the stent that are bent during crimping and expansion of the stent.
- longitudinal flexibility is important for successful delivery of the stent.
- radial rigidity and strength are vital characteristics in deployment and for holding open a body lumen.
- the pattern that makes up the stent allows the stent to be radially expandable and longitudinally flexible. The pattern should be designed to maintain the necessary longitudinal flexibility and radial rigidity of the stent.
- One technique for strengthening the bending portions of a stent is to laser cut the stent such as to widen the bending portions of the stent.
- the stent flips upwards or “chip” when the strut is bent during crimping and/or expansion.
- the present invention is directed to a stent and a method of manufacturing a stent.
- a method comprises disposing a polymeric tube into a cylindrical mold, the cylindrical mold having a variable diameter along a portion of the inside surface of the mold; radially expanding the tube by blowing a gas or liquid into the cylindrical mold, the outside surface of the tube conforming to the variable diameter portion of the inside surface of the mold, causing the radially expanded tube to have a variable diameter along the conformed length of the tube; and fabricating a stent from the expanded tube.
- a method comprises disposing a polymeric tube into a cylindrical mold, the cylindrical mold comprising an inner surface facing the polymeric tube, the inner surface having an inner diameter that varies along an axial length of the cylindrical mold.
- the method further comprises expanding the polymeric tube in radially outward directions to form an expanded tube, the expanding including blowing a gas or liquid into the cylindrical mold so that an outer surface of the polymeric tube conforms to the inner surface of the cylindrical mold and so that the outer surface of the expanded tube has an outer diameter that varies along an axial length of the expanded tube.
- the method further comprises fabricating a stent from the expanded tube.
- a stent is formed from a polymeric tube that was disposed into a cylindrical mold, subsequently expanded in radially outward directions in the cylindrical mold, and subsequently removed from the cylindrical mold and cut to form interconnecting stent struts, wherein the polymeric tube has an outer surface with an outer diameter that, after being removed from the cylindrical mold, varies along an axial length of the polymeric tube.
- FIG. 1 depicts a tube for use in forming a stent.
- FIG. 2 depicts a three-dimensional stent with a pattern.
- FIG. 3A depicts an axial cross-section of a polymeric tube inserted in a cylindrical mold having indentations.
- FIG. 3B depicts an axial cross-section of a radially expanded tube after blow molding a gas or liquid into the mold.
- FIG. 3C depicts an axial cross-section of a radially expanded tube having protrusions.
- FIG. 3D depicts another embodiment of an axial cross-section of a radially expanded tube having protrusions.
- FIG. 4A depicts an axial cross-section of a polymeric tube inserted in a cylindrical mold having protrusions.
- FIG. 4B depicts an axial cross-section of a radially expanded tube after blow molding a gas into the mold.
- FIG. 4C depicts an axial cross-section of a radially expanded tube having indentions.
- FIG. 5A depicts an axial cross-section of a polymeric tube inserted in a tapered cylindrical mold.
- FIG. 5B depicts an axial cross-section of a radially expanded tube after blowing a gas or liquid into the mold.
- FIG. 5C depicts an axial cross-section of a tapered radially expanded tube.
- FIG. 6A depicts a portion of a strut having a uniform thickness and a relatively wider bending portion.
- FIG. 6B depicts a portion of a strut after crimping, where portion of strut has a uniform thickness and the wider bending portion that has flipped upward.
- FIG. 7A depicts a portion of a strut before crimping having a relatively thicker bending portion.
- FIG. 7B depicts a portion of a strut after crimping having a relatively thicker bending portion.
- FIG. 7C depicts a portion of a strut having a relatively thicker bending portion, and, in addition, features on the abluminal or luminal side.
- FIG. 8 depicts one embodiment of a machine-controlled system for laser machining a tube, circumventing any features that have been formed on the stent.
- FIG. 9( a ) depicts a close-up axial view of a region where a laser beam interacts with a tube having features.
- FIG. 9( b ) depicts a close-up end view of a region where a laser beam interacts with a tube having features.
- Stress refers to force per unit area, as in the force acting through a small area within a plane. Stress can be divided into components, normal and parallel to the plane, called normal stress and shear stress, respectively. True stress denotes the stress where force and area are measured at the same time. Conventional stress, as applied to tension and compression tests, is force divided by the original gauge length.
- Elastic limit refers to the maximum stress that a material will withstand without permanent deformation.
- “Strength” refers to the maximum stress in a direction in testing which a material will withstand prior to fracture. The ultimate strength is calculated from the maximum load applied during the test divided by the original cross-sectional area.
- Stress refers to the amount of elongation or compression that occurs in a material at a given stress or load. Elongation may be defined as the increase in length which occurs when subjected to stress. It is typically expressed as a percentage of the original length.
- the “glass transition temperature,” Tg is the temperature at which the amorphous domains of a polymer change from a brittle vitreous state to a plastic state at atmospheric pressure.
- Tg corresponds to the temperature where the onset of segmental motion in the chains of the polymer occurs.
- Tg of a given polymer can be dependent on the heating rate and can be influenced by the thermal history of the polymer.
- molecular orientation may be induced with applied stress since rotation of polymer chains, and hence segmental mobility is possible.
- Tg and the melting temperature of the polymer, T m rotational barriers exist, however, the barriers are not great enough to substantially prevent segmental mobility.
- the temperature of a polymer is increased above Tg, the energy barriers to rotation decrease and segmental mobility of polymer chains tend to increase. As a result, as the temperature increases, molecular orientation is more easily induced with applied stress.
- Embodiments of the method can be used to fabricate devices including, but not limited to, stents, balloon-expandable stents, stent-grafts, and grafts.
- Various embodiments to manufacture a stent with desirable features are described herein.
- Some embodiments to manufacture the device include fabricating the stent from a polymer conduit or tube.
- the tube may be cylindrical or substantially cylindrical in shape.
- FIG. 1 depicts a tube 100 .
- Tube 100 is a cylinder with an outside diameter 110 and an inside diameter 120 .
- FIG. 1 also depicts an outside surface 130 and a cylindrical axis 140 of tube 100 .
- the “diameter” of the tube refers to the outside diameter of tube.
- the polymeric tube may be used to fabricate a stent. Fabrication may include forming a pattern that includes at least one interconnecting element or strut on the elongated tube.
- the stent may be formed by laser cutting a pattern on the elongated tube. Representative examples of lasers that may be used include an ultra fast laser, excimer, carbon dioxide, and YAG. Chemical etching may also be used to form a pattern on the elongated tube.
- FIG. 2 depicts a three-dimensional view of a stent 150 which may be formed from tube 100 in FIG. 1 .
- FIG. 2 depicts a pattern or network of struts 160 . The pattern is not limited to the depicted stent pattern.
- the polymeric tube for use in manufacturing a stent has a desired strength and flexibility in the longitudinal direction, as shown by an arrow 135 in FIG. 1 , and in the transverse or radial direction, as shown by an arrow 145 in FIG. 1 .
- the desired strength and flexibility can be induced by radial expansion and/or axial deformation.
- a tube can be radially deformed by blow molding.
- the invention provides blow molding a tube to form a tube having a variable diameter and/or features such as indentations.
- the cylindrical mold may include features where, upon conveying a gas or liquid at a selected pressure into a proximal end of the polymeric tube, the cylindrical mold acts to control the diameter of the expanded polymeric tube by limiting the expansion to the inside diameter of the cylindrical mold.
- the pressure of the conveyed gas may be used to control the expansion of the polymeric tube to a desired diameter, while a distal end of the polymeric tube may be closed.
- the inside diameter of the cylindrical mold with features corresponds to the desired shape and diameter of the formed polymeric tube.
- the inside surface of the mold may include features such as protrusions, projections, grooves, indentations, flanges, overhangs, and extensions. Other features are also possible.
- the embodiments disclosed herein allow formation of a tube with a variable diameter and/or features on the outside surface of the tube.
- the invention also provides fabricating a stent having portions that are thicker than other portions of the stent.
- FIG. 3A depicts an axial cross-section of a polymeric tube 300 with an outside diameter 310 positioned within a cylindrical mold 320 having indentations 330 on the inside surface of the mold 320 .
- Cylindrical mold 320 with indentations 330 acts to limit the expansion of polymeric tube 300 to the inside surface of mold 320 .
- the indentations form a tube 300 with a variable diameter.
- Polymeric tube 300 may be closed at a distal end 350 to conform to the outside surface of mold 320 .
- Any gas such as air, may be conveyed, as indicated by an arrow 360 , into an open proximal end 370 of polymeric tube 300 .
- a liquid may also be conveyed into the open proximal end 370 to provide pressure on the inside of the tube.
- the gas or liquid can be heated to a temperature sufficient to deform the polymeric tube. This temperature can be above the glass transition temperature of the polymer.
- the pressure of the gas is selected to sufficiently expand the polymeric tube to conform to the inside surface of cylindrical mold 320 .
- Polymeric tube 300 may be heated by the gas or liquid to a temperature above ambient temperature, for example above Tg of the polymer. Alternatively, heat may be applied to the exterior of cylindrical mold 320 .
- the conveyed gas combined with the applied heat may act to radially expand polymeric tube 300 , as indicated by an arrow 380 .
- FIG. 3B depicts an axial cross-section of a polymeric tube 300 having protrusions 390 that are formed after blowing a gas at a selected temperature and pressure into the cylindrical mold 320 .
- tube 300 includes protrusions 390 that are formed during the blow molding process.
- FIG. 4A depicts an axial cross-section of a polymeric tube 400 having an outside diameter 310 positioned within a cylindrical mold 410 having protrusions 420 .
- Cylindrical mold 410 with protrusions 420 acts to limit the expansion of polymeric tube 400 to an expanded diameter 340 , which conforms to the surface of the mold.
- Cylindrical mold 410 includes protrusions 420 .
- FIG. 4B depicts an axial cross-section of a radially expanded tube 400 after blowing a gas or liquid at a selected temperature and pressure into the cylindrical mold 410 . As depicted in FIG.
- indentations 430 are formed in polymeric tube 400 by blow molding polymeric tube 400 against cylindrical mold 410 having protrusions 420 .
- tube 400 includes grooves 430 formed during the blow molding process.
- the indentations in the tube are arranged in the tube as desired. For example, if the indentations are to be used as depots to hold drugs, the indentations may be arranged linearly along the entire length of the tube. Also, the indentations may be arranged such that when the pattern is cut into the tube, the indentations encompass portions of the stent requiring flexibility.
- the indentations can be of any shape, not just circular.
- FIG. 4D depicts stent strut 440 having indentations 450 and a protrusion 460 on the bending portion 465 of the stent portion.
- FIG. 5A depicts an axial cross-section of a polymeric tube 500 with an outside diameter 520 positioned within a cylindrical mold 510 , where cylindrical mold 510 is tapered along its length.
- Cylindrical mold 510 acts to limit the expansion of polymeric tube 500 to an expanded diameter 530 on one end of the polymeric tube 500 and diameter 540 on the other end of the polymeric tube 500 .
- Cylindrical mold 510 has a tapered diameter, such that the diameter 540 on the end of formed tube 500 is expanded more than the other end 530 of tube upon blow molding.
- FIG. 5B depicts an axial cross-section of a radially expanded tube 500 after blowing a gas at a selected temperature and pressure into the cylindrical mold 510 .
- a tapered polymeric tube 500 is formed by expanding polymeric tube 500 to conform to the inner surface of cylindrical mold 510 .
- formed tube 500 includes a tapered diameter from diameter 540 to diameter 530 .
- the tapered stent may be adapted to improve the attachment of the stent to the delivery system and facilitate the delivery of the mounted stent into and through a bodily lumen.
- FIG. 5 depict a uniform tapering shape, the invention includes arbitrary axial cross-sections which can be formed by blow molding.
- selected portions of the stent using blow molding may be formed to have greater or lesser mass relative to other portions of the stent.
- high strain regions may be made up of more polymeric mass relative to other portions of the stent.
- lower strain regions that require flexibility may be of a lesser mass.
- FIG. 6A depicts a portion of a strut 600 having a uniform thickness on the sidewall 635 and a relatively wider bending portion 620 , where width is indicated by “W”. That is, thickness 610 of bending portion 620 is substantially the same as the thickness of ends 615 of strut 600 .
- Strut 600 includes a luminal or abluminal side and a side wall 625 . The bending portion 620 of strut 600 is bent during crimping the stent onto a balloon-catheter assembly and during expansion of the stent when the stent is deployed.
- bending portion 620 of strut 600 is caused to flip upwards or “chip” when the strut is bent 600 during crimping and/or expansion as depicted by arrows 630 . Chipping can become problematic because stent protrusion and non-uniform apposition on the vessel wall is unwanted in a vessel wall.
- FIGS. 7A and 7B depicts a portion of a strut 700 having a variable thickness. That is, thickness 710 of the bending portion 720 is greater than the thickness of the ends 715 of strut 700 .
- Strut 700 includes a bending portion 720 that is bent during crimping the stent onto a balloon-catheter assembly and/or during expanding the stent when the stent is deployed. As depicted in FIG. 7B , the bending portion 720 of strut 700 may have a low or no tendency to flip outward when the strut is bent during crimping, for example.
- the greater thickness of the sidewall 735 in bending portion 720 of the stent strut 700 provides a greater strength with little or no out of plane bending as shown in FIG. 6B .
- strut portions requiring greater flexibility, such as linking struts may be formed to be thinner than other strut portions. Therefore, with blow molding, parts having various thicknesses can be designed to be at selected portions of a stent.
- a portion of a strut 700 has a thicker bending portion 720 as well as protrusions 730 located at selected portions of abluminal or luminal surface 725 .
- a portion of strut is made to be thicker as well as wider relative to other portions of the stent.
- the polymeric tube may be heated such that the temperature of the polymeric tube is greater than or equal to Tg and less than T m of the polymer. Heating above Tg facilitates expansion, since a polymer becomes more flexible above Tg.
- cooling the deformed tube may be cooled at a temperature below an ambient temperature to below the Tg of the polymer.
- cooling the deformed polymer tube may include cooling the deformed polymer tube at a temperature at or near an ambient temperature to below the Tg of the polymer.
- the tube may be laser cut to form a stent.
- a stent may be fabricated by use of a laser beam collimated to a 1 to 10 mm beam diameter. The tube is then cut by focusing a beam, such as a 0.5 to 2 mm wide beam, on the polymeric tube. A stent pattern may then be cut into the tube by moving the tube in an axial and rotary direction with respect to the cutting beam or by moving the beam.
- FIG. 8 depicts an embodiment of a portion of a machine-controlled system for laser machining a tube.
- a polymeric tube 800 is disposed in a rotatable collet fixture 810 of a machine-controlled apparatus 820 for positioning tube 800 relative to a laser 830 .
- tube 800 is rotated and moved axially relative to laser 830 which may also be machine-controlled.
- the laser selectively removes the material from the tube resulting in a pattern cut into the tube 800 .
- the tube 800 is therefore cut into the discrete pattern of a finished stent.
- the process of cutting a pattern for the stent into the tube is automated except for loading and unloading the length of tube 800 .
- the process may be done, for example, using a CNC-opposing collet fixture 840 for axial rotation of the length of tubing.
- Collet fixture 840 may act in conjunction with a CNC X/Y table 850 to move the length of tube axially relative to a machine-controlled laser 830 as described.
- the entire space between collets can be patterned using a laser set-up of the foregoing example.
- the program for control of the apparatus is dependent on the particular configuration used and the pattern formed. Therefore, a pattern that circumvents any features formed on the tube can be accomplished using the program for control of the apparatus.
- Machining a fine structure also requires the ability to manipulate the tube with precision.
- CNC equipment manufactured and sold by Anorad Corporation in Hauppauge, N.Y. may be used for positioning the tube.
- a unique rotary mechanism may be used that allows the computer program to be written as if the pattern were being machined from a flat sheet, allowing utilization of both circular and linear interpolation in programming.
- the axial and rotary motion may be controlled by a CNC system.
- a CNC controlled axis may also control the focus position on the polymeric tube. After indexing the CNC system to a specific position on tube, the system traces the pattern in the x, y, z coordinate system.
- the finished structure of the stent is very small, a precision drive mechanism is required that supports and drives both ends of the tubular structure as it is cut. Since both ends are driven, they are preferably aligned and precisely synchronized. Otherwise, as the stent is being cut, the stent may twist and distort.
- the stent produces stents with a fine precision structure cut from a small diameter thin-walled cylindrical tube.
- Cutting a fine structure around features on a stent surface created by the present invention e.g., a 0.0035 inch strut width (0.889 mm)
- a laser technology adapted to micro-machine the tube may be implemented according to the present embodiments.
- FIGS. 9( a ) and 9 ( b ) show that apparatus 900 incorporates a monocular viewing, focusing, and cutting head 930 .
- a rotary axis 940 and X-Y stages 950 for rotating and translating the work piece are also shown.
- a CNC controller 960 is also incorporated into apparatus 300 .
- FIG. 9( a ) depicts a close-up axial view of the region where the laser beam interacts with the substrate target material.
- a laser beam 900 is focused by a focusing lens 910 on a tube 920 is supported by a CNC controlled rotary collet 930 at one end and a tube support pin 940 at another end.
- the laser can incorporate a coaxial gas jet assembly 950 having a coaxial gas jet 960 and a nozzle 970 that helps to remove debris from the kerf and cools the region where the beam interacts with the material as the beam cuts and vaporizes a substrate.
- Coaxial gas jet nozzle 970 e.g., 0.018 inch diameter (0.457 mm)
- a focused beam 980 with approximately 0.010 inch (2.54 mm) between a tip 990 of nozzle 970 and a tube 920 .
- an optical system for modifying a laser beam according to the embodiments described herein may be positioned between cutting head 930 (depicted in FIGS. 9( a ) and 9 ( b )) and the substrate target material.
- a mandrel 992 e.g., approx. 0.034 inch diameter (0.864 mm) supported by a mandrel beam block 995 is placed inside the tube and is allowed to roll on the bottom of the tube 985 as the pattern is cut, which acts as a beam/debris block protecting the far wall inner diameter.
- a close-up end view along mandrel beam block 995 shows laser beam 980 impinging on tube 985 in FIG. 9( b ).
- the laser enables the machining of narrow kerf widths to circumvent the features formed on the stent surface, while minimizing the heat input into the material.
- smooth, narrow cuts in a tube with very fine geometries are made without damaging the narrow struts that define the stent structure.
- the stent can be made partially or completely from a biodegradable, bioabsorbable, or biostable polymer.
- Biostable refers to polymers that are not biodegradable.
- biodegradable, bioabsorbable, and bioerodable are used interchangeably and refer to polymers that are capable of being completely degraded and/or eroded when exposed to bodily fluids such as blood and can be gradually resorbed, absorbed and/or eliminated by the body.
- the processes of breaking down and eventual absorption and elimination of the polymer can be caused by, for example, hydrolysis, metabolic processes, bulk or surface erosion, and the like.
- the stent is intended to remain in the body for a duration of time until its intended function is accomplished.
- polymers that may be used to fabricate a stent using the methods disclosed herein include poly(N-acetylglucosamine) (Chitin), Chitoson, poly(hydroxyvalerate), poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(D,L-lactic acid), poly(glycolic acid-co-trimethylene carbonate), poly(trimethylene carbonate), co-poly(ether-esters) (e.g.
- PEO/PLA polyphosphazenes
- biomolecules such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid
- polyurethanes silicones
- polyesters polyolefins, polyisobutylene and ethylene-alphaolefin copolymers
- acrylic polymers and copolymers other than polyacrylates vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides,
- polymers that may be especially well suited for use in fabricating a stent according to the methods disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluororpropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), poly(L-lactic acid), poly(caprolactone), ethylene-vinyl acetate copolymers, and polyethylene glycol.
- EVAL ethylene vinyl alcohol copolymer
- poly(vinylidene fluoride-co-hexafluororpropene) e.g., SOLEF 21508, available from Solvay Solexis
Abstract
A polymeric stent has an inner surface with an inner diameter that tapers continuously in size. A method for manufacturing a stent includes blow molding a polymeric tube within a mold having a tapered, cylindrical cavity such that the polymeric tube attains a corresponding tapered shape. The tapered tube is used as a substrate from which a laser cuts interconnecting stent struts.
Description
- This application is a divisional of application Ser. No. 11/479,111, filed Jun. 30, 2006, now U.S. Pat. No. 7,740,791, the entire contents of which is incorporated herein by reference.
- This invention relates to a method of fabricating a stent.
- This invention relates to radially expandable endoprostheses which are adapted to be implanted in a body lumen. An “endoprosthesis” corresponds to an artificial implantable medical device that is placed inside the body. A “lumen” refers to a cavity of a tubular organ such as a blood vessel. These endoprostheses are commonly referred to as stents. Stents are generally cylindrically shaped devices which function to hold open and sometimes expand a segment of a blood vessel or other anatomical lumen such as urinary tracts and bile ducts. Stents are often used in the treatment of atherosclerotic stenosis in blood vessels. “Stenosis” refers to a narrowing or constriction of the diameter of a bodily passage or orifice. In such treatments, stents reinforce body vessels and prevent restenosis following angioplasty in the vascular system. “Restenosis” refers to the reoccurrence of stenosis in a blood vessel or heart valve after it has been treated (as by balloon angioplasty or valvuloplasty) with apparent success.
- The cylindrical structure of stents is typically composed of a scaffolding that includes a pattern or network of interconnecting structural elements or struts. The scaffolding can be formed from wires, tubes, or planar films of material rolled into a cylindrical shape. In addition, a medicated stent may be fabricated by coating the surface of either a metallic or polymeric scaffolding with a polymeric carrier. The polymeric carrier can include an active agent or drug. Furthermore, the pattern that makes up the stent allows the stent to be radially expandable and longitudinally flexible. Longitudinal flexibility facilitates delivery of the stent and radial rigidity is needed to hold open a body lumen. The pattern should be designed to maintain the necessary longitudinal flexibility and radial rigidity of the stent.
- A number of techniques have been suggested to fabricate stents from tubes and planar films or sheets. One such technique involves laser cutting or etching a pattern onto a material. Laser cutting may be performed on a planar film of a material which is then rolled into a tube. Alternatively, a desired pattern may be etched directly onto a tube. Fabricating a stent from a tube is preferable due to time and cost considerations. Other techniques involve cutting a desired pattern into a sheet or a tube via chemical etching or electrical discharge machining. Laser cutting of stents has been described in a number of publications including U.S. Pat. No. 5,780,807 to Saunders, U.S. Pat. No. 5,922,005 to Richter and U.S. Pat. No. 5,906,759 to Richter.
- It is desirable for a stent to have certain mechanical properties to facilitate delivery and deployment of a stent, especially in the bending portions of the stent that are bent during crimping and expansion of the stent. For example, longitudinal flexibility is important for successful delivery of the stent. In addition, radial rigidity and strength are vital characteristics in deployment and for holding open a body lumen. The pattern that makes up the stent allows the stent to be radially expandable and longitudinally flexible. The pattern should be designed to maintain the necessary longitudinal flexibility and radial rigidity of the stent. One technique for strengthening the bending portions of a stent is to laser cut the stent such as to widen the bending portions of the stent. However, upon crimping a stent that includes wider bending portions, oftentimes the stent flips upwards or “chip” when the strut is bent during crimping and/or expansion.
- What is needed in the art is a method of fabricating a stent to mechanically strengthen the stent in selected portions.
- Briefly and in general terms, the present invention is directed to a stent and a method of manufacturing a stent.
- In aspects of the invention, a method comprises disposing a polymeric tube into a cylindrical mold, the cylindrical mold having a variable diameter along a portion of the inside surface of the mold; radially expanding the tube by blowing a gas or liquid into the cylindrical mold, the outside surface of the tube conforming to the variable diameter portion of the inside surface of the mold, causing the radially expanded tube to have a variable diameter along the conformed length of the tube; and fabricating a stent from the expanded tube.
- In other aspects of the invention, a method comprises disposing a polymeric tube into a cylindrical mold, the cylindrical mold comprising an inner surface facing the polymeric tube, the inner surface having an inner diameter that varies along an axial length of the cylindrical mold. The method further comprises expanding the polymeric tube in radially outward directions to form an expanded tube, the expanding including blowing a gas or liquid into the cylindrical mold so that an outer surface of the polymeric tube conforms to the inner surface of the cylindrical mold and so that the outer surface of the expanded tube has an outer diameter that varies along an axial length of the expanded tube. The method further comprises fabricating a stent from the expanded tube.
- In other aspects of the invention, a stent is formed from a polymeric tube that was disposed into a cylindrical mold, subsequently expanded in radially outward directions in the cylindrical mold, and subsequently removed from the cylindrical mold and cut to form interconnecting stent struts, wherein the polymeric tube has an outer surface with an outer diameter that, after being removed from the cylindrical mold, varies along an axial length of the polymeric tube.
-
FIG. 1 depicts a tube for use in forming a stent. -
FIG. 2 depicts a three-dimensional stent with a pattern. -
FIG. 3A depicts an axial cross-section of a polymeric tube inserted in a cylindrical mold having indentations. -
FIG. 3B depicts an axial cross-section of a radially expanded tube after blow molding a gas or liquid into the mold. -
FIG. 3C depicts an axial cross-section of a radially expanded tube having protrusions. -
FIG. 3D depicts another embodiment of an axial cross-section of a radially expanded tube having protrusions. -
FIG. 4A depicts an axial cross-section of a polymeric tube inserted in a cylindrical mold having protrusions. -
FIG. 4B depicts an axial cross-section of a radially expanded tube after blow molding a gas into the mold. -
FIG. 4C depicts an axial cross-section of a radially expanded tube having indentions. -
FIG. 5A depicts an axial cross-section of a polymeric tube inserted in a tapered cylindrical mold. -
FIG. 5B depicts an axial cross-section of a radially expanded tube after blowing a gas or liquid into the mold. -
FIG. 5C depicts an axial cross-section of a tapered radially expanded tube. -
FIG. 6A depicts a portion of a strut having a uniform thickness and a relatively wider bending portion. -
FIG. 6B depicts a portion of a strut after crimping, where portion of strut has a uniform thickness and the wider bending portion that has flipped upward. -
FIG. 7A depicts a portion of a strut before crimping having a relatively thicker bending portion. -
FIG. 7B depicts a portion of a strut after crimping having a relatively thicker bending portion. -
FIG. 7C depicts a portion of a strut having a relatively thicker bending portion, and, in addition, features on the abluminal or luminal side. -
FIG. 8 depicts one embodiment of a machine-controlled system for laser machining a tube, circumventing any features that have been formed on the stent. -
FIG. 9( a) depicts a close-up axial view of a region where a laser beam interacts with a tube having features. -
FIG. 9( b) depicts a close-up end view of a region where a laser beam interacts with a tube having features. - For the purposes of the present invention, the following terms and definitions apply:
- “Stress” refers to force per unit area, as in the force acting through a small area within a plane. Stress can be divided into components, normal and parallel to the plane, called normal stress and shear stress, respectively. True stress denotes the stress where force and area are measured at the same time. Conventional stress, as applied to tension and compression tests, is force divided by the original gauge length.
- “Elastic limit” refers to the maximum stress that a material will withstand without permanent deformation.
- “Strength” refers to the maximum stress in a direction in testing which a material will withstand prior to fracture. The ultimate strength is calculated from the maximum load applied during the test divided by the original cross-sectional area.
- “Strain” refers to the amount of elongation or compression that occurs in a material at a given stress or load. Elongation may be defined as the increase in length which occurs when subjected to stress. It is typically expressed as a percentage of the original length.
- The “glass transition temperature,” Tg, is the temperature at which the amorphous domains of a polymer change from a brittle vitreous state to a plastic state at atmospheric pressure. In other words, the Tg corresponds to the temperature where the onset of segmental motion in the chains of the polymer occurs. Tg of a given polymer can be dependent on the heating rate and can be influenced by the thermal history of the polymer. Above Tg, molecular orientation may be induced with applied stress since rotation of polymer chains, and hence segmental mobility is possible. Between Tg and the melting temperature of the polymer, Tm, rotational barriers exist, however, the barriers are not great enough to substantially prevent segmental mobility. As the temperature of a polymer is increased above Tg, the energy barriers to rotation decrease and segmental mobility of polymer chains tend to increase. As a result, as the temperature increases, molecular orientation is more easily induced with applied stress.
- Embodiments of the method can be used to fabricate devices including, but not limited to, stents, balloon-expandable stents, stent-grafts, and grafts. Various embodiments to manufacture a stent with desirable features are described herein. Some embodiments to manufacture the device include fabricating the stent from a polymer conduit or tube. The tube may be cylindrical or substantially cylindrical in shape. For example,
FIG. 1 depicts atube 100.Tube 100 is a cylinder with anoutside diameter 110 and aninside diameter 120.FIG. 1 also depicts anoutside surface 130 and acylindrical axis 140 oftube 100. When referred to below, unless otherwise specified, the “diameter” of the tube refers to the outside diameter of tube. - The polymeric tube may be used to fabricate a stent. Fabrication may include forming a pattern that includes at least one interconnecting element or strut on the elongated tube. The stent may be formed by laser cutting a pattern on the elongated tube. Representative examples of lasers that may be used include an ultra fast laser, excimer, carbon dioxide, and YAG. Chemical etching may also be used to form a pattern on the elongated tube.
FIG. 2 depicts a three-dimensional view of astent 150 which may be formed fromtube 100 inFIG. 1 .FIG. 2 depicts a pattern or network ofstruts 160. The pattern is not limited to the depicted stent pattern. - The polymeric tube for use in manufacturing a stent has a desired strength and flexibility in the longitudinal direction, as shown by an
arrow 135 inFIG. 1 , and in the transverse or radial direction, as shown by anarrow 145 inFIG. 1 . The desired strength and flexibility can be induced by radial expansion and/or axial deformation. A tube can be radially deformed by blow molding. The invention provides blow molding a tube to form a tube having a variable diameter and/or features such as indentations. There are many advantages to fabricating tubes with a variable diameter and/or features such as indentions, such as increased stent retention and features such as pockets filled with drugs or radio-opaque substances. - Several embodiments disclosed herein provide applying radial pressure to a polymeric tube by positioning the polymeric tube within a cylindrical mold. The cylindrical mold may include features where, upon conveying a gas or liquid at a selected pressure into a proximal end of the polymeric tube, the cylindrical mold acts to control the diameter of the expanded polymeric tube by limiting the expansion to the inside diameter of the cylindrical mold. The pressure of the conveyed gas may be used to control the expansion of the polymeric tube to a desired diameter, while a distal end of the polymeric tube may be closed. The inside diameter of the cylindrical mold with features corresponds to the desired shape and diameter of the formed polymeric tube. The inside surface of the mold may include features such as protrusions, projections, grooves, indentations, flanges, overhangs, and extensions. Other features are also possible. The embodiments disclosed herein allow formation of a tube with a variable diameter and/or features on the outside surface of the tube. The invention also provides fabricating a stent having portions that are thicker than other portions of the stent.
-
FIG. 3A depicts an axial cross-section of apolymeric tube 300 with an outside diameter 310 positioned within acylindrical mold 320 havingindentations 330 on the inside surface of themold 320.Cylindrical mold 320 withindentations 330 acts to limit the expansion ofpolymeric tube 300 to the inside surface ofmold 320. The indentations form atube 300 with a variable diameter. When thepolymeric tube 300 expands from diameter 310 todiameter 340,protrusions 390 are formed on the outside surface of thepolymeric tube 300. -
Polymeric tube 300 may be closed at adistal end 350 to conform to the outside surface ofmold 320. Any gas, such as air, may be conveyed, as indicated by anarrow 360, into an openproximal end 370 ofpolymeric tube 300. A liquid may also be conveyed into the openproximal end 370 to provide pressure on the inside of the tube. The gas or liquid can be heated to a temperature sufficient to deform the polymeric tube. This temperature can be above the glass transition temperature of the polymer. The pressure of the gas is selected to sufficiently expand the polymeric tube to conform to the inside surface ofcylindrical mold 320.Polymeric tube 300 may be heated by the gas or liquid to a temperature above ambient temperature, for example above Tg of the polymer. Alternatively, heat may be applied to the exterior ofcylindrical mold 320. The conveyed gas combined with the applied heat may act to radially expandpolymeric tube 300, as indicated by anarrow 380. -
FIG. 3B depicts an axial cross-section of apolymeric tube 300 havingprotrusions 390 that are formed after blowing a gas at a selected temperature and pressure into thecylindrical mold 320. As depicted inFIG. 3C ,tube 300 includesprotrusions 390 that are formed during the blow molding process. -
FIG. 4A depicts an axial cross-section of apolymeric tube 400 having an outside diameter 310 positioned within acylindrical mold 410 havingprotrusions 420.Cylindrical mold 410 withprotrusions 420 acts to limit the expansion ofpolymeric tube 400 to an expandeddiameter 340, which conforms to the surface of the mold. When apolymeric tube 400 expands from diameter 310,indentations 430 are formed inpolymeric tube 400.Cylindrical mold 410 includesprotrusions 420.FIG. 4B depicts an axial cross-section of a radially expandedtube 400 after blowing a gas or liquid at a selected temperature and pressure into thecylindrical mold 410. As depicted inFIG. 4B ,indentations 430 are formed inpolymeric tube 400 by blow moldingpolymeric tube 400 againstcylindrical mold 410 havingprotrusions 420. As depicted inFIG. 4C ,tube 400 includesgrooves 430 formed during the blow molding process. The indentations in the tube are arranged in the tube as desired. For example, if the indentations are to be used as depots to hold drugs, the indentations may be arranged linearly along the entire length of the tube. Also, the indentations may be arranged such that when the pattern is cut into the tube, the indentations encompass portions of the stent requiring flexibility. The indentations can be of any shape, not just circular. The indentations of the tube are formed to coincide with the specific parts of the stent pattern. For example,FIG. 4D depictsstent strut 440 havingindentations 450 and aprotrusion 460 on the bendingportion 465 of the stent portion. One advantage to forming features on a stent by blow molding rather than by laser cutting is that blow molding avoids deleterious effects on the mechanical portions of the stent caused by heat from lasers that create a heat affected zone. -
FIG. 5A depicts an axial cross-section of apolymeric tube 500 with anoutside diameter 520 positioned within acylindrical mold 510, wherecylindrical mold 510 is tapered along its length.Cylindrical mold 510 acts to limit the expansion ofpolymeric tube 500 to an expandeddiameter 530 on one end of thepolymeric tube 500 anddiameter 540 on the other end of thepolymeric tube 500.Cylindrical mold 510 has a tapered diameter, such that thediameter 540 on the end of formedtube 500 is expanded more than theother end 530 of tube upon blow molding.FIG. 5B depicts an axial cross-section of a radially expandedtube 500 after blowing a gas at a selected temperature and pressure into thecylindrical mold 510. A taperedpolymeric tube 500 is formed by expandingpolymeric tube 500 to conform to the inner surface ofcylindrical mold 510. As depicted inFIG. 5C , formedtube 500 includes a tapered diameter fromdiameter 540 todiameter 530. There are many advantages to using a tapered stent. For example, the tapered stent may be adapted to improve the attachment of the stent to the delivery system and facilitate the delivery of the mounted stent into and through a bodily lumen. AlthoughFIG. 5 depict a uniform tapering shape, the invention includes arbitrary axial cross-sections which can be formed by blow molding. - As mentioned previously, selected portions of the stent using blow molding may be formed to have greater or lesser mass relative to other portions of the stent. For example, high strain regions may be made up of more polymeric mass relative to other portions of the stent. Similarly, lower strain regions that require flexibility may be of a lesser mass.
-
FIG. 6A depicts a portion of astrut 600 having a uniform thickness on thesidewall 635 and a relativelywider bending portion 620, where width is indicated by “W”. That is,thickness 610 of bendingportion 620 is substantially the same as the thickness ofends 615 ofstrut 600.Strut 600 includes a luminal or abluminal side and aside wall 625. The bendingportion 620 ofstrut 600 is bent during crimping the stent onto a balloon-catheter assembly and during expansion of the stent when the stent is deployed. If the abluminal orluminal surface 625 of bendingportion 620 is made wider, bendingportion 620 ofstrut 600 is caused to flip upwards or “chip” when the strut is bent 600 during crimping and/or expansion as depicted byarrows 630. Chipping can become problematic because stent protrusion and non-uniform apposition on the vessel wall is unwanted in a vessel wall. -
FIGS. 7A and 7B depicts a portion of astrut 700 having a variable thickness. That is,thickness 710 of the bendingportion 720 is greater than the thickness of theends 715 ofstrut 700.Strut 700 includes a bendingportion 720 that is bent during crimping the stent onto a balloon-catheter assembly and/or during expanding the stent when the stent is deployed. As depicted inFIG. 7B , the bendingportion 720 ofstrut 700 may have a low or no tendency to flip outward when the strut is bent during crimping, for example. The greater thickness of thesidewall 735 in bendingportion 720 of thestent strut 700 provides a greater strength with little or no out of plane bending as shown inFIG. 6B . In addition, strut portions requiring greater flexibility, such as linking struts, may be formed to be thinner than other strut portions. Therefore, with blow molding, parts having various thicknesses can be designed to be at selected portions of a stent. - In one embodiment, as depicted in
FIG. 7C , a portion of astrut 700 has athicker bending portion 720 as well asprotrusions 730 located at selected portions of abluminal orluminal surface 725. In one embodiment, a portion of strut is made to be thicker as well as wider relative to other portions of the stent. - In one embodiment, the polymeric tube may be heated such that the temperature of the polymeric tube is greater than or equal to Tg and less than Tm of the polymer. Heating above Tg facilitates expansion, since a polymer becomes more flexible above Tg.
- After the polymeric tube is radially expanded by blow molding the tube, it may be desirable to cool the radially expanded tube below the Tg of the polymer to retain induced molecular orientation. Some embodiments may include cooling the deformed tube prior to fabrication of the medical device. The deformed tube may be cooled at a temperature below an ambient temperature to below the Tg of the polymer. Alternatively, cooling the deformed polymer tube may include cooling the deformed polymer tube at a temperature at or near an ambient temperature to below the Tg of the polymer.
- After the polymeric tube is radially expanded by blow molding the tube, the tube may be laser cut to form a stent. A stent may be fabricated by use of a laser beam collimated to a 1 to 10 mm beam diameter. The tube is then cut by focusing a beam, such as a 0.5 to 2 mm wide beam, on the polymeric tube. A stent pattern may then be cut into the tube by moving the tube in an axial and rotary direction with respect to the cutting beam or by moving the beam.
-
FIG. 8 depicts an embodiment of a portion of a machine-controlled system for laser machining a tube. InFIG. 8 , apolymeric tube 800 is disposed in a rotatable collet fixture 810 of a machine-controlledapparatus 820 forpositioning tube 800 relative to alaser 830. According to machine-encoded instructions,tube 800 is rotated and moved axially relative tolaser 830 which may also be machine-controlled. The laser selectively removes the material from the tube resulting in a pattern cut into thetube 800. Thetube 800 is therefore cut into the discrete pattern of a finished stent. - The process of cutting a pattern for the stent into the tube is automated except for loading and unloading the length of
tube 800. Referring again toFIG. 8 , the process may be done, for example, using a CNC-opposingcollet fixture 840 for axial rotation of the length of tubing.Collet fixture 840 may act in conjunction with a CNC X/Y table 850 to move the length of tube axially relative to a machine-controlledlaser 830 as described. The entire space between collets can be patterned using a laser set-up of the foregoing example. The program for control of the apparatus is dependent on the particular configuration used and the pattern formed. Therefore, a pattern that circumvents any features formed on the tube can be accomplished using the program for control of the apparatus. - Machining a fine structure also requires the ability to manipulate the tube with precision. CNC equipment manufactured and sold by Anorad Corporation in Hauppauge, N.Y. may be used for positioning the tube. In addition, a unique rotary mechanism may be used that allows the computer program to be written as if the pattern were being machined from a flat sheet, allowing utilization of both circular and linear interpolation in programming. Thus, the axial and rotary motion may be controlled by a CNC system. A CNC controlled axis may also control the focus position on the polymeric tube. After indexing the CNC system to a specific position on tube, the system traces the pattern in the x, y, z coordinate system. Since the finished structure of the stent is very small, a precision drive mechanism is required that supports and drives both ends of the tubular structure as it is cut. Since both ends are driven, they are preferably aligned and precisely synchronized. Otherwise, as the stent is being cut, the stent may twist and distort.
- The stent produces stents with a fine precision structure cut from a small diameter thin-walled cylindrical tube. Cutting a fine structure around features on a stent surface created by the present invention (e.g., a 0.0035 inch strut width (0.889 mm)) requires precise laser focusing and minimal heat input. To satisfy these requirements, a laser technology adapted to micro-machine the tube may be implemented according to the present embodiments.
- Additionally,
FIGS. 9( a) and 9(b) show thatapparatus 900 incorporates a monocular viewing, focusing, and cuttinghead 930. Arotary axis 940 andX-Y stages 950 for rotating and translating the work piece are also shown. ACNC controller 960 is also incorporated intoapparatus 300. -
FIG. 9( a) depicts a close-up axial view of the region where the laser beam interacts with the substrate target material. Alaser beam 900 is focused by a focusinglens 910 on atube 920 is supported by a CNC controlledrotary collet 930 at one end and atube support pin 940 at another end. - As shown by
FIG. 9( a), the laser can incorporate a coaxialgas jet assembly 950 having acoaxial gas jet 960 and anozzle 970 that helps to remove debris from the kerf and cools the region where the beam interacts with the material as the beam cuts and vaporizes a substrate. Coaxial gas jet nozzle 970 (e.g., 0.018 inch diameter (0.457 mm)) is centered around afocused beam 980 with approximately 0.010 inch (2.54 mm) between atip 990 ofnozzle 970 and atube 920. In certain embodiments, an optical system for modifying a laser beam according to the embodiments described herein may be positioned between cutting head 930 (depicted inFIGS. 9( a) and 9(b)) and the substrate target material. - It may also be necessary to block
laser beam 980 as it cuts through the top surface of the tube to prevent the beam, along with the molten material and debris from the cut, from impinging on the inside opposite surface oftube 990. To this end, a mandrel 992 (e.g., approx. 0.034 inch diameter (0.864 mm)) supported by amandrel beam block 995 is placed inside the tube and is allowed to roll on the bottom of thetube 985 as the pattern is cut, which acts as a beam/debris block protecting the far wall inner diameter. A close-up end view alongmandrel beam block 995 showslaser beam 980 impinging ontube 985 inFIG. 9( b). - Hence, the laser enables the machining of narrow kerf widths to circumvent the features formed on the stent surface, while minimizing the heat input into the material. In this way, smooth, narrow cuts in a tube with very fine geometries are made without damaging the narrow struts that define the stent structure.
- The stent can be made partially or completely from a biodegradable, bioabsorbable, or biostable polymer. Biostable refers to polymers that are not biodegradable. The terms biodegradable, bioabsorbable, and bioerodable are used interchangeably and refer to polymers that are capable of being completely degraded and/or eroded when exposed to bodily fluids such as blood and can be gradually resorbed, absorbed and/or eliminated by the body. The processes of breaking down and eventual absorption and elimination of the polymer can be caused by, for example, hydrolysis, metabolic processes, bulk or surface erosion, and the like. For stents made from a biodegradable polymer, the stent is intended to remain in the body for a duration of time until its intended function is accomplished.
- Representative examples of polymers that may be used to fabricate a stent using the methods disclosed herein include poly(N-acetylglucosamine) (Chitin), Chitoson, poly(hydroxyvalerate), poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(D,L-lactic acid), poly(glycolic acid-co-trimethylene carbonate), poly(trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, biomolecules (such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid), polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, acrylic polymers and copolymers other than polyacrylates, vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers, polyurethanes, rayon, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose. Additional representative examples of polymers that may be especially well suited for use in fabricating a stent according to the methods disclosed herein include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluororpropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), poly(L-lactic acid), poly(caprolactone), ethylene-vinyl acetate copolymers, and polyethylene glycol.
- While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that changes and modifications can be made without departing from this invention in its broader aspects. Therefore, the appended claims are to encompass within their scope all such changes and modifications as fall within the true spirit and scope of this invention.
Claims (20)
1. Method of manufacturing a stent, the method comprising:
disposing a polymeric tube into a cylindrical mold, the cylindrical mold comprising an inner surface facing the polymeric tube, the inner surface having an inner diameter that varies along an axial length of the cylindrical mold;
expanding the polymeric tube in radially outward directions to form an expanded tube, the expanding including blowing a gas or liquid into the cylindrical mold so that an outer surface of the polymeric tube conforms to the inner surface of the cylindrical mold and so that the outer surface of the expanded tube has an outer diameter that varies along an axial length of the expanded tube; and
fabricating a stent from the expanded tube.
2. The method of claim 1 , wherein the outer surface of the expanded tube is tapered such that the outer diameter increases from an end segment of the expanded tube to an opposite end segment of the expanded tube.
3. The method of claim 2 , wherein the outer diameter increases continuously from the end segment to the opposite end segment.
4. The method of claim 1 , wherein the outer surface forms a conical shape.
5. The method of claim 1 , wherein the expanded tube comprises a first end segment, a second end segment opposite the first end segment, and a central segment between the first and second end segments, and wherein the outer surface of the expanded tube is tapered such that the outer diameter is greater at the first end segment than at the central segment and is greater at the central segment than at the second end segment.
6. The method of claim 1 , wherein the expanded tube comprises a first end segment, a second end segment opposite the first end segment, and a central segment between the first and second end segments, and wherein the outer diameter is larger at the central segment than at the first and second end segments.
7. The method of claim 1 , wherein the expanded tube comprises a first end segment, a second end segment opposite the first end segment, and a central segment between the first and second end segments, and wherein the outer surface of the expanded tube is tapered such that the outer diameter increases from the first end segment to the central segment.
8. The method of claim 7 , wherein the outer diameter increases from the second end segment to the central segment.
9. The method of claim 1 , further comprising heating the polymeric tube to a temperature above Tg of the polymer either before or during the expanding.
10. The method of claim 1 , further comprising heating the polymeric tube to a temperature above Tg of the polymer before and during the expanding.
11. The method of claim 10 , wherein the polymeric tube is heated by the liquid or gas blown into the cylindrical mold.
12. The method of claim 1 , wherein the fabricating includes cutting a pattern of interconnecting struts from the expanded tube.
13. The method of claim 12 , wherein the pattern of interconnecting struts is configured to be crimped and expanded.
14. The method of claim 1 , wherein the polymeric tube is a biodegradable and/or biostable polymer.
15. The method of claim 1 , wherein the polymeric tube is made of poly(L-lactic acid).
16. The method of claim 1 , wherein the polymeric tube is made of poly(lactide-co-glycolide).
17. A stent formed from a polymeric tube that was disposed into a cylindrical mold, subsequently expanded in radially outward directions in the cylindrical mold, and subsequently removed from the cylindrical mold and cut to form interconnecting stent struts, wherein the polymeric tube has an outer surface with an outer diameter that, after being removed from the cylindrical mold, varies along an axial length of the polymeric tube.
18. The stent of claim 17 , wherein the cylindrical mold comprises an inner surface having an inner diameter that varies along an axial length of the cylindrical mold, and the outer surface of the polymeric tube has a shape corresponding to the inner surface of the cylindrical mold.
19. The method of claim 1 , wherein the polymeric tube comprises a first end segment, a second end segment opposite the first end segment, and a central segment between the first and second end segments, and wherein after the polymeric tube is removed from the cylindrical mold, the outer surface of the polymeric tube is tapered such that the outer diameter is greater at the first end segment than at the central segment and is greater at the central segment than at the second end segment.
20. The method of claim 1 , wherein the polymeric tube comprises a first end segment, a second end segment opposite the first end segment, and a central segment between the first and second end segments, and wherein after the polymeric tube is removed from the cylindrical mold, the outer diameter is larger at the central segment than at the first and second end segments.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/816,275 US20100256742A1 (en) | 2006-06-30 | 2010-06-15 | Tapered Polymeric Stent And Method Of Fabricating Same |
US14/542,395 US9808982B2 (en) | 2006-06-30 | 2014-11-14 | Tapered polymeric stent and method of fabricating same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/479,111 US7740791B2 (en) | 2006-06-30 | 2006-06-30 | Method of fabricating a stent with features by blow molding |
US12/816,275 US20100256742A1 (en) | 2006-06-30 | 2010-06-15 | Tapered Polymeric Stent And Method Of Fabricating Same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/479,111 Division US7740791B2 (en) | 2006-06-30 | 2006-06-30 | Method of fabricating a stent with features by blow molding |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/542,395 Division US9808982B2 (en) | 2006-06-30 | 2014-11-14 | Tapered polymeric stent and method of fabricating same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100256742A1 true US20100256742A1 (en) | 2010-10-07 |
Family
ID=38683542
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/479,111 Expired - Fee Related US7740791B2 (en) | 2006-06-30 | 2006-06-30 | Method of fabricating a stent with features by blow molding |
US12/816,275 Abandoned US20100256742A1 (en) | 2006-06-30 | 2010-06-15 | Tapered Polymeric Stent And Method Of Fabricating Same |
US14/542,395 Expired - Fee Related US9808982B2 (en) | 2006-06-30 | 2014-11-14 | Tapered polymeric stent and method of fabricating same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/479,111 Expired - Fee Related US7740791B2 (en) | 2006-06-30 | 2006-06-30 | Method of fabricating a stent with features by blow molding |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/542,395 Expired - Fee Related US9808982B2 (en) | 2006-06-30 | 2014-11-14 | Tapered polymeric stent and method of fabricating same |
Country Status (2)
Country | Link |
---|---|
US (3) | US7740791B2 (en) |
WO (1) | WO2008005390A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110277305A1 (en) * | 2007-05-04 | 2011-11-17 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US20110282428A1 (en) * | 2010-05-13 | 2011-11-17 | Boston Scientific Scimed, Inc. | Biodegradable composite stent |
US20120012569A1 (en) * | 2010-07-14 | 2012-01-19 | Danny Severino | Fabric cutting system and method |
CN102371670A (en) * | 2011-10-14 | 2012-03-14 | 微创医疗器械(上海)有限公司 | New processing method of biodegradable stent |
US20120280432A1 (en) * | 2011-05-06 | 2012-11-08 | Industrial Technology Research Institute | Method for manufacturing bioabsorbable stents |
US9198785B2 (en) | 2010-01-30 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
WO2016100789A1 (en) * | 2014-12-19 | 2016-06-23 | Boston Scientific Scimed, Inc. | Stent with anti-migration features |
US9827119B2 (en) | 2010-01-30 | 2017-11-28 | Abbott Cardiovascular Systems Inc. | Polymer scaffolds having a low crossing profile |
US10307274B2 (en) | 2011-07-29 | 2019-06-04 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US10610969B2 (en) | 2010-07-14 | 2020-04-07 | Atex Technologies Inc. | Fabric cutting system and method |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US8501079B2 (en) | 2009-09-14 | 2013-08-06 | Abbott Cardiovascular Systems Inc. | Controlling crystalline morphology of a bioabsorbable stent |
US7731890B2 (en) | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US8012402B2 (en) * | 2008-08-04 | 2011-09-06 | Abbott Cardiovascular Systems Inc. | Tube expansion process for semicrystalline polymers to maximize fracture toughness |
US20110066222A1 (en) * | 2009-09-11 | 2011-03-17 | Yunbing Wang | Polymeric Stent and Method of Making Same |
US8268228B2 (en) | 2007-12-11 | 2012-09-18 | Abbott Cardiovascular Systems Inc. | Method of fabricating stents from blow molded tubing |
US8747879B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US8778256B1 (en) | 2004-09-30 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Deformation of a polymer tube in the fabrication of a medical article |
US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US20140107761A1 (en) | 2004-07-26 | 2014-04-17 | Abbott Cardiovascular Systems Inc. | Biodegradable stent with enhanced fracture toughness |
US20060020330A1 (en) | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US7875233B2 (en) * | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
US8043553B1 (en) | 2004-09-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article |
US8173062B1 (en) | 2004-09-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube in fabricating a medical article |
US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US8814930B2 (en) | 2007-01-19 | 2014-08-26 | Elixir Medical Corporation | Biodegradable endoprosthesis and methods for their fabrication |
US20080177373A1 (en) | 2007-01-19 | 2008-07-24 | Elixir Medical Corporation | Endoprosthesis structures having supporting features |
US20130150943A1 (en) | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
US7666342B2 (en) * | 2007-06-29 | 2010-02-23 | Abbott Cardiovascular Systems Inc. | Method of manufacturing a stent from a polymer tube |
US8066757B2 (en) * | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US8545514B2 (en) * | 2008-04-11 | 2013-10-01 | Covidien Lp | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US9198687B2 (en) * | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US7998524B2 (en) * | 2007-12-10 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Methods to improve adhesion of polymer coatings over stents |
US20090192455A1 (en) * | 2008-01-07 | 2009-07-30 | David Ferrera | Novel enhanced ptna rapid exchange type of catheter system |
AU2009217354B2 (en) | 2008-02-22 | 2013-10-10 | Covidien Lp | Methods and apparatus for flow restoration |
US20090287295A1 (en) * | 2008-05-13 | 2009-11-19 | Contiliano Joseph H | Method of Manufacturing a Polymeric Stent with a Hybrid Support Structure |
US8765040B2 (en) | 2008-08-11 | 2014-07-01 | Abbott Cardiovascular Systems Inc. | Medical device fabrication process including strain induced crystallization with enhanced crystallization |
US8372332B2 (en) * | 2008-08-11 | 2013-02-12 | Abbott Cardiovascular Systems Inc. | Fabricating an implantable medical device from an amorphous or very low crystallinity polymer construct |
WO2010048052A1 (en) * | 2008-10-22 | 2010-04-29 | Boston Scientific Scimed, Inc. | Shape memory tubular stent with grooves |
US20100244305A1 (en) * | 2009-03-24 | 2010-09-30 | Contiliano Joseph H | Method of manufacturing a polymeric stent having improved toughness |
US20100244334A1 (en) * | 2009-03-24 | 2010-09-30 | Contiliano Joseph H | Method of manufacturing a polymeric stent having a circumferential ring configuration |
US20100244304A1 (en) * | 2009-03-31 | 2010-09-30 | Yunbing Wang | Stents fabricated from a sheet with increased strength, modulus and fracture toughness |
US9278485B2 (en) | 2009-09-04 | 2016-03-08 | Abbott Cardiovascular Systems Inc. | Method to prevent stent damage caused by laser cutting |
US8373090B2 (en) | 2009-09-04 | 2013-02-12 | Abbott Cardiovascular Systems Inc. | Method and apparatus to prevent stent damage caused by laser cutting |
US8370120B2 (en) | 2010-04-30 | 2013-02-05 | Abbott Cardiovascular Systems Inc. | Polymeric stents and method of manufacturing same |
US9095420B2 (en) * | 2011-01-24 | 2015-08-04 | Tufts Medical Center, Inc. | Endovascular stent |
WO2014081947A1 (en) | 2012-11-21 | 2014-05-30 | Syed Mubin I | System for the intravascular placement of a medical device |
CN104853695B (en) | 2013-03-15 | 2017-09-15 | 波士顿科学国际有限公司 | The bracket coating of anti-displacement micro-patterning |
US9549806B2 (en) | 2013-08-12 | 2017-01-24 | Abbott Cardiovascular Systems Inc. | Bioresorbable laryngotracheal stent and methods of treatment |
US10327890B2 (en) * | 2014-01-22 | 2019-06-25 | Biotronik Ag | Thermochemically treated miniature tubes as semifinished products for vascular stents |
CN105142688B (en) | 2014-02-04 | 2018-01-19 | 艾博特心血管系统公司 | Cause novolimus and drug delivery stent or support member of the coating with minimum bonded amount with the coating based on novolimus and lactide |
US10064745B2 (en) | 2014-03-18 | 2018-09-04 | Abbott Cardiovascular Systems Inc. | Tapered scaffolds |
US9855156B2 (en) | 2014-08-15 | 2018-01-02 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9730819B2 (en) | 2014-08-15 | 2017-08-15 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9480588B2 (en) | 2014-08-15 | 2016-11-01 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9259339B1 (en) | 2014-08-15 | 2016-02-16 | Elixir Medical Corporation | Biodegradable endoprostheses and methods of their fabrication |
US9636244B2 (en) | 2015-04-09 | 2017-05-02 | Mubin I. Syed | Apparatus and method for proximal to distal stent deployment |
US9908297B2 (en) | 2015-08-20 | 2018-03-06 | Abbott Cardiovascular Systems Inc. | Scaffolds having variable wall thickness |
US10492936B2 (en) | 2015-10-30 | 2019-12-03 | Ram Medical Innovations, Llc | Apparatus and method for improved access of procedural catheter in tortuous vessels |
US10779976B2 (en) | 2015-10-30 | 2020-09-22 | Ram Medical Innovations, Llc | Apparatus and method for stabilization of procedural catheter in tortuous vessels |
US11020256B2 (en) | 2015-10-30 | 2021-06-01 | Ram Medical Innovations, Inc. | Bifurcated “Y” anchor support for coronary interventions |
US10327929B2 (en) | 2015-10-30 | 2019-06-25 | Ram Medical Innovations, Llc | Apparatus and method for stabilization of procedural catheter in tortuous vessels |
US11622872B2 (en) | 2016-05-16 | 2023-04-11 | Elixir Medical Corporation | Uncaging stent |
ES2873887T3 (en) | 2016-05-16 | 2021-11-04 | Elixir Medical Corp | Stent release |
US10173031B2 (en) | 2016-06-20 | 2019-01-08 | Mubin I. Syed | Interchangeable flush/selective catheter |
US10653510B2 (en) | 2016-11-09 | 2020-05-19 | Boston Scientific Scimed, Inc. | Stent including displacement capabilities |
JP7017394B2 (en) * | 2017-12-14 | 2022-02-08 | 株式会社小糸製作所 | Light guide device |
US10857014B2 (en) | 2018-02-18 | 2020-12-08 | Ram Medical Innovations, Llc | Modified fixed flat wire bifurcated catheter and its application in lower extremity interventions |
US11672681B2 (en) | 2019-01-28 | 2023-06-13 | Mubin I. Syed | Variable flow stent |
WO2021146021A1 (en) | 2020-01-13 | 2021-07-22 | Boston Scientific Scimed, Inc. | Anti-migration stent |
US11786355B2 (en) | 2020-01-30 | 2023-10-17 | Boston Scientific Scimed, Inc. | Radial adjusting self-expanding stent with anti-migration features |
EP4215663A1 (en) | 2022-01-20 | 2023-07-26 | ecobrain AG | Process for manufacturing components from reclaimed textile fabric products |
Citations (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2922255A (en) * | 1956-03-22 | 1960-01-26 | Gen Electric | Mold apparatus for casting glass |
US3636956A (en) * | 1970-05-13 | 1972-01-25 | Ethicon Inc | Polylactide sutures |
US4547416A (en) * | 1980-11-19 | 1985-10-15 | Metal Box Limited | Thermoplastics articles and method and apparatus for making them |
US4698196A (en) * | 1985-12-24 | 1987-10-06 | Xerox Corporation | Method and apparatus for extruding creaseless thin walled tubes |
US4702884A (en) * | 1986-07-03 | 1987-10-27 | The United States Of America As Represented By The Secretary Of The Navy | Glass-lined pipes |
US4957687A (en) * | 1983-11-07 | 1990-09-18 | Bulent Akman | Method for making profiled plastic tubes such as corrugated tubes |
US4987025A (en) * | 1985-08-12 | 1991-01-22 | Mitsui Petrochemical Industries, Ltd. | Inflation film of ultrahigh molecular weight polyethylene |
US5087394A (en) * | 1989-11-09 | 1992-02-11 | Scimed Life Systems, Inc. | Method for forming an inflatable balloon for use in a catheter |
US5108416A (en) * | 1990-02-13 | 1992-04-28 | C. R. Bard, Inc. | Stent introducer system |
US5116365A (en) * | 1991-02-22 | 1992-05-26 | Cordis Corporation | Stent apparatus and method for making |
US5147302A (en) * | 1989-04-21 | 1992-09-15 | Scimed Life Systems, Inc. | Method of shaping a balloon of a balloon catheter |
US5500013A (en) * | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US5591230A (en) * | 1994-09-07 | 1997-01-07 | Global Therapeutics, Inc. | Radially expandable stent |
US5628786A (en) * | 1995-05-12 | 1997-05-13 | Impra, Inc. | Radially expandable vascular graft with resistance to longitudinal compression and method of making same |
US5670161A (en) * | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US5780807A (en) * | 1994-11-28 | 1998-07-14 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5891386A (en) * | 1997-04-25 | 1999-04-06 | Medtronic, Inc. | Method for making catheter balloons |
US5906759A (en) * | 1996-12-26 | 1999-05-25 | Medinol Ltd. | Stent forming apparatus with stent deforming blades |
US5922005A (en) * | 1994-10-27 | 1999-07-13 | Medinol Ltd. | Stent fabrication method |
US20010014821A1 (en) * | 1998-11-16 | 2001-08-16 | Mohamad Ike Juman | Balloon catheter and stent delivery system having enhanced stent retention |
US20020077592A1 (en) * | 1994-06-30 | 2002-06-20 | Boston Scientific Corporation | Replenishable stent and delivery system |
US20020138133A1 (en) * | 1999-11-09 | 2002-09-26 | Scimed Life Systems, Inc. | Stent with variable properties |
US20020151965A1 (en) * | 1998-05-29 | 2002-10-17 | Micro Therapeutics, Inc. | Rolled stent with waveform perforation pattern |
US20030028241A1 (en) * | 2001-08-02 | 2003-02-06 | Stinson Jonathan Swift | Method for enhancing sheet or tubing metal stent radiopacity |
US20030028246A1 (en) * | 1999-11-19 | 2003-02-06 | Palmaz Julio C. | Compliant implantable medical devices and methods of making same |
US6521865B1 (en) * | 2001-06-14 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Pulsed fiber laser cutting system for medical implants |
US20030055488A1 (en) * | 1998-09-08 | 2003-03-20 | Keiji Igaki | Method for manufacturing yarn for vessel stent |
US20030083732A1 (en) * | 2001-10-25 | 2003-05-01 | Stinson Jonathan S. | Balloon expandable polymer stent with reduced elastic recoil |
US6572813B1 (en) * | 2000-01-13 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Balloon forming process |
US6574851B1 (en) * | 2000-07-31 | 2003-06-10 | Advanced Cardiovascular Systems, Inc. | Stent made by rotational molding or centrifugal casting and method for making the same |
US6626939B1 (en) * | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US20030187158A1 (en) * | 2000-11-30 | 2003-10-02 | The Procter & Gamble Company | High molecular weight polyolefin and catalyst and process for polymerising said polyolefin |
US20030208254A1 (en) * | 2002-05-03 | 2003-11-06 | James Shortt | Method and apparatus for mounting a stent onto a stent delivery system |
US6645422B2 (en) * | 1997-05-14 | 2003-11-11 | Jomed, Inc. | Method for manufacturing a balloon for a dilation catheter |
US20030226833A1 (en) * | 2001-02-15 | 2003-12-11 | Scimed Life Systems, Inc. | Laser cutting of stents and other medical devices |
US20040000361A1 (en) * | 2002-06-27 | 2004-01-01 | Thomas Trozera | Method of manufacturing an implantable stent having improved mechanical properties |
US20040098090A1 (en) * | 2002-11-14 | 2004-05-20 | Williams Michael S. | Polymeric endoprosthesis and method of manufacture |
US20040191404A1 (en) * | 2001-04-12 | 2004-09-30 | Syed Hossainy | Method of making a variable surface area stent |
US20040199242A1 (en) * | 2001-12-27 | 2004-10-07 | James Hong | Hybrid intravascular stent |
US20050004663A1 (en) * | 2001-05-07 | 2005-01-06 | Llanos Gerard H. | Heparin barrier coating for controlled drug release |
US20050033412A1 (en) * | 2000-09-28 | 2005-02-10 | Wu Steven Z. | Method of making an implantable medical device |
US20050137678A1 (en) * | 2003-12-22 | 2005-06-23 | Medtronic Vascular, Inc. | Low profile resorbable stent |
US20050146085A1 (en) * | 2004-01-07 | 2005-07-07 | Scimed Life Systems, Inc. | Process and apparatus for forming medical device balloons |
US20050177130A1 (en) * | 2004-02-10 | 2005-08-11 | Angioscore, Inc. | Balloon catheter with spiral folds |
US20050187615A1 (en) * | 2004-02-23 | 2005-08-25 | Williams Michael S. | Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture |
US20050196485A1 (en) * | 2004-01-13 | 2005-09-08 | Martin Cass | Heat transfer system for a mold |
US20060020330A1 (en) * | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US20060076708A1 (en) * | 2004-09-30 | 2006-04-13 | Bin Huang | Method of fabricating a biaxially oriented implantable medical device |
US7070615B1 (en) * | 2000-03-13 | 2006-07-04 | Keiji Igaki | Linear material for blood vessel stent and blood vessel stent utilizing same |
US7083639B2 (en) * | 2001-09-26 | 2006-08-01 | Medtronic Vascular, Inc. | Stent delivery catheter with grooved balloon and methods of making same |
US20060211952A1 (en) * | 2005-03-18 | 2006-09-21 | Wilson-Cook Medical Inc. | Wire guides having novel outer surface areas and reservoirs for enhancing hydrophilic properties and delivering therapeutic agents |
US20060224226A1 (en) * | 2005-03-31 | 2006-10-05 | Bin Huang | In-vivo radial orientation of a polymeric implantable medical device |
US20060229695A1 (en) * | 2005-04-12 | 2006-10-12 | Brown Daniel G | Stents with profiles for gripping a balloon catheter and molds for fabricating stents |
US7128868B2 (en) * | 2003-01-10 | 2006-10-31 | Boston Scientific Scimed, Inc. | Balloon wing forming apparatus and method |
US20070253996A1 (en) * | 2006-04-28 | 2007-11-01 | Huang Bin | Method of fabricating an implantable medical device by controlling crystalline structure |
US20070253999A1 (en) * | 2006-04-28 | 2007-11-01 | Bin Huang | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US20070282433A1 (en) * | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US7306585B2 (en) * | 2004-09-30 | 2007-12-11 | Engineering Resources Group, Inc. | Guide catheter |
US20070293938A1 (en) * | 2006-06-15 | 2007-12-20 | Gale David C | Methods of fabricating stents with enhanced fracture toughness |
US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US20090005860A1 (en) * | 2007-06-27 | 2009-01-01 | Gale David C | Method to fabricate a stent having selected morphology to reduce restenosis |
US20090001633A1 (en) * | 2007-06-29 | 2009-01-01 | Limon Timothy A | Method Of Manufacturing A Stent From A Polymer Tube |
US20090012598A1 (en) * | 2004-06-29 | 2009-01-08 | Abbate Anthony J | Method of fabricating an implantable medical device by deformation of a tube or a sheet |
US7476245B2 (en) * | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US20090146348A1 (en) * | 2007-12-11 | 2009-06-11 | Bin Huang | Method of fabrication a stent from blow molded tubing |
Family Cites Families (286)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US111149A (en) * | 1871-01-24 | Improvement in toy carriages | ||
US187495A (en) * | 1877-02-20 | Improvement in wrappers for bonbons | ||
US62148A (en) * | 1867-02-19 | Francis mil-liken | ||
US111590A (en) * | 1871-02-07 | Improvement in lubricators for loose pulleys | ||
US100865A (en) * | 1870-03-15 | crosby | ||
US161114A (en) * | 1875-03-23 | Improvement in hay-elevators | ||
US236565A (en) * | 1881-01-11 | Traction-engine | ||
GB1237035A (en) | 1969-08-20 | 1971-06-30 | Tsi Travmatologii I Ortopedii | Magnesium-base alloy for use in bone surgery |
US3900632A (en) | 1970-02-27 | 1975-08-19 | Kimberly Clark Co | Laminate of tissue and random laid continuous filament web |
US3839743A (en) | 1972-04-21 | 1974-10-08 | A Schwarcz | Method for maintaining the normal integrity of blood |
US4104410A (en) | 1973-12-21 | 1978-08-01 | Malecki George J | Processing of green vegetables for color retention in canning |
US4110497A (en) | 1976-07-02 | 1978-08-29 | Snyder Manufacturing Co., Ltd. | Striped laminate and method and apparatus for making same |
JPS6037735B2 (en) * | 1978-10-18 | 1985-08-28 | 住友電気工業株式会社 | Artificial blood vessel |
DE2928007A1 (en) | 1979-07-11 | 1981-01-15 | Riess Guido Dr | BONE IMPLANT BODY FOR PROSTHESES AND BONE CONNECTORS AND METHOD FOR THE PRODUCTION THEREOF |
US4346028A (en) | 1979-12-14 | 1982-08-24 | Monsanto Company | Asbestiform crystalline calcium sodium or lithium phosphate, preparation and compositions |
DE3019996A1 (en) | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | HOHLORGAN |
FR2510411B1 (en) | 1981-07-30 | 1986-09-12 | Ethicon Inc | CROSSLINKED POLYDIOXANONE SURGICAL APPARATUS AND METHOD FOR THE PRODUCTION THEREOF |
US4902289A (en) * | 1982-04-19 | 1990-02-20 | Massachusetts Institute Of Technology | Multilayer bioreplaceable blood vessel prosthesis |
US4517687A (en) | 1982-09-15 | 1985-05-21 | Meadox Medicals, Inc. | Synthetic woven double-velour graft |
US4656083A (en) | 1983-08-01 | 1987-04-07 | Washington Research Foundation | Plasma gas discharge treatment for improving the biocompatibility of biomaterials |
US4594407A (en) | 1983-09-20 | 1986-06-10 | Allied Corporation | Prosthetic devices derived from krebs-cycle dicarboxylic acids and diols |
US5197977A (en) * | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US4633873A (en) * | 1984-04-26 | 1987-01-06 | American Cyanamid Company | Surgical repair mesh |
US4596574A (en) | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
CH671337A5 (en) | 1984-06-19 | 1989-08-31 | Ceskoslovenska Akademie Ved | |
US4879135A (en) | 1984-07-23 | 1989-11-07 | University Of Medicine And Dentistry Of New Jersey | Drug bonded prosthesis and process for producing same |
IT1186142B (en) * | 1984-12-05 | 1987-11-18 | Medinvent Sa | TRANSLUMINAL IMPLANTATION DEVICE |
US4718907A (en) * | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
US4818559A (en) | 1985-08-08 | 1989-04-04 | Sumitomo Chemical Company, Limited | Method for producing endosseous implants |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4743252A (en) | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
EP0257091B1 (en) | 1986-02-24 | 1993-07-28 | Robert E. Fischell | An intravascular stent and percutaneous insertion system |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
EP0241838B1 (en) | 1986-04-07 | 1992-04-15 | Agency Of Industrial Science And Technology | Antithrombogenic material |
US4740207A (en) | 1986-09-10 | 1988-04-26 | Kreamer Jeffry W | Intralumenal graft |
US4723549A (en) * | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4722335A (en) * | 1986-10-20 | 1988-02-02 | Vilasi Joseph A | Expandable endotracheal tube |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4816339A (en) * | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US5527337A (en) | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
US5059211A (en) | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4877030A (en) | 1988-02-02 | 1989-10-31 | Andreas Beck | Device for the widening of blood vessels |
US5192311A (en) * | 1988-04-25 | 1993-03-09 | Angeion Corporation | Medical implant and method of making |
US4994298A (en) * | 1988-06-07 | 1991-02-19 | Biogold Inc. | Method of making a biocompatible prosthesis |
US5502158A (en) * | 1988-08-08 | 1996-03-26 | Ecopol, Llc | Degradable polymer composition |
US5328471A (en) | 1990-02-26 | 1994-07-12 | Endoluminal Therapeutics, Inc. | Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens |
US5019090A (en) | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
US5085629A (en) * | 1988-10-06 | 1992-02-04 | Medical Engineering Corporation | Biodegradable stent |
US4977901A (en) | 1988-11-23 | 1990-12-18 | Minnesota Mining And Manufacturing Company | Article having non-crosslinked crystallized polymer coatings |
CH678393A5 (en) | 1989-01-26 | 1991-09-13 | Ulrich Prof Dr Med Sigwart | |
JP2927942B2 (en) | 1989-01-27 | 1999-07-28 | オーストラリアン メンブレイン アンド バイオテクノロジィ リサーチ インスティチュート | Gating of receptor membranes and ionophores |
US5163958A (en) | 1989-02-02 | 1992-11-17 | Cordis Corporation | Carbon coated tubular endoprosthesis |
US5289831A (en) * | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
NZ228382A (en) | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
US5108755A (en) | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5100429A (en) * | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
US4990158A (en) | 1989-05-10 | 1991-02-05 | United States Surgical Corporation | Synthetic semiabsorbable tubular prosthesis |
US5084065A (en) * | 1989-07-10 | 1992-01-28 | Corvita Corporation | Reinforced graft assembly |
US5971954A (en) | 1990-01-10 | 1999-10-26 | Rochester Medical Corporation | Method of making catheter |
EP0441516B1 (en) | 1990-02-08 | 1995-03-29 | Howmedica Inc. | Inflatable stent |
US5545208A (en) | 1990-02-28 | 1996-08-13 | Medtronic, Inc. | Intralumenal drug eluting prosthesis |
US5156623A (en) | 1990-04-16 | 1992-10-20 | Olympus Optical Co., Ltd. | Sustained release material and method of manufacturing the same |
US5123917A (en) | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
US5290271A (en) * | 1990-05-14 | 1994-03-01 | Jernberg Gary R | Surgical implant and method for controlled release of chemotherapeutic agents |
US5279594A (en) * | 1990-05-23 | 1994-01-18 | Jackson Richard R | Intubation devices with local anesthetic effect for medical use |
US6060451A (en) | 1990-06-15 | 2000-05-09 | The National Research Council Of Canada | Thrombin inhibitors based on the amino acid sequence of hirudin |
US5236447A (en) | 1990-06-29 | 1993-08-17 | Nissho Corporation | Artificial tubular organ |
US5342395A (en) | 1990-07-06 | 1994-08-30 | American Cyanamid Co. | Absorbable surgical repair devices |
US5112457A (en) | 1990-07-23 | 1992-05-12 | Case Western Reserve University | Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of biomedical implants |
US5455040A (en) | 1990-07-26 | 1995-10-03 | Case Western Reserve University | Anticoagulant plasma polymer-modified substrate |
SE9102448D0 (en) | 1990-08-28 | 1991-08-26 | Meadox Medicals Inc | RAVEL RESISTANT, SELF-SUPPORTING WOVEN GRAFT |
EP0546021B1 (en) * | 1990-08-28 | 1995-11-08 | Meadox Medicals, Inc. | Self-supporting woven vascular graft |
US5108417A (en) | 1990-09-14 | 1992-04-28 | Interface Biomedical Laboratories Corp. | Anti-turbulent, anti-thrombogenic intravascular stent |
US5258020A (en) * | 1990-09-14 | 1993-11-02 | Michael Froix | Method of using expandable polymeric stent with memory |
US5163952A (en) | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
DE69116130T2 (en) | 1990-10-18 | 1996-05-15 | Ho Young Song | SELF-EXPANDING, ENDOVASCULAR DILATATOR |
US5104410A (en) | 1990-10-22 | 1992-04-14 | Intermedics Orthopedics, Inc | Surgical implant having multiple layers of sintered porous coating and method |
US5163951A (en) | 1990-12-27 | 1992-11-17 | Corvita Corporation | Mesh composite graft |
CS277367B6 (en) | 1990-12-29 | 1993-01-13 | Krajicek Milan | Three-layered vascular prosthesis |
EP0525210A4 (en) * | 1991-02-20 | 1993-07-28 | Tdk Corporation | Composite bio-implant and production method therefor |
CA2082410C (en) | 1991-03-08 | 2003-09-23 | Hideo Tamai | Luminal stent, holding structure therefor and device for attaching luminal stent |
US5383925A (en) * | 1992-09-14 | 1995-01-24 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
US5356433A (en) | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
US6515009B1 (en) * | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5234457A (en) | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
US5282860A (en) * | 1991-10-16 | 1994-02-01 | Olympus Optical Co., Ltd. | Stent tube for medical use |
JP3313113B2 (en) | 1991-10-21 | 2002-08-12 | ペプテック リミテッド | Biocompatible implants for controlling ovulation in mares |
US5167614A (en) | 1991-10-29 | 1992-12-01 | Medical Engineering Corporation | Prostatic stent |
US5756476A (en) | 1992-01-14 | 1998-05-26 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of cell proliferation using antisense oligonucleotides |
CA2087132A1 (en) | 1992-01-31 | 1993-08-01 | Michael S. Williams | Stent capable of attachment within a body lumen |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
JPH07505316A (en) | 1992-03-31 | 1995-06-15 | ボストン サイエンティフィック コーポレーション | medical wire |
DE4222380A1 (en) | 1992-07-08 | 1994-01-13 | Ernst Peter Prof Dr M Strecker | Endoprosthesis implantable percutaneously in a patient's body |
US5306294A (en) | 1992-08-05 | 1994-04-26 | Ultrasonic Sensing And Monitoring Systems, Inc. | Stent construction of rolled configuration |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
AU664913B2 (en) | 1992-08-13 | 1995-12-07 | Implico B.V. | A hydrogel composition and methods of making it |
US5853408A (en) | 1992-08-20 | 1998-12-29 | Advanced Cardiovascular Systems, Inc. | In-vivo modification of the mechanical properties of surgical devices |
US5342621A (en) | 1992-09-15 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Antithrombogenic surface |
US5830461A (en) | 1992-11-25 | 1998-11-03 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods for promoting wound healing and treating transplant-associated vasculopathy |
US5342348A (en) | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
EP0604022A1 (en) | 1992-12-22 | 1994-06-29 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method for its manufacture |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
FR2702954B1 (en) | 1993-03-03 | 1997-09-26 | Andrew H Cragg | Prosthesis and intraluminal implant. |
FI92465C (en) * | 1993-04-14 | 1994-11-25 | Risto Tapani Lehtinen | A method for handling endo-osteal materials |
US5441515A (en) | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
EG20321A (en) | 1993-07-21 | 1998-10-31 | Otsuka Pharma Co Ltd | Medical material and process for producing the same |
WO1995003010A1 (en) | 1993-07-23 | 1995-02-02 | Cook Incorporated | A flexible stent having a pattern formed from a sheet of material |
JPH09501932A (en) | 1993-08-26 | 1997-02-25 | ジェネティックス・インスティテュート・インコーポレイテッド | Nerve regeneration using human and bone morphogenetic proteins |
EP0659389B1 (en) | 1993-10-20 | 1998-04-22 | Schneider (Europe) Ag | Endoprothese |
US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
US5389106A (en) * | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5599301A (en) * | 1993-11-22 | 1997-02-04 | Advanced Cardiovascular Systems, Inc. | Motor control system for an automatic catheter inflation system |
SE501288C2 (en) | 1993-11-30 | 1995-01-09 | Corimed Gmbh | Process for preparing ceramic implant material, preferably hydroxylapatite having ceramic implant material |
US5626611A (en) | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
US5556413A (en) | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
HUT76094A (en) | 1994-03-18 | 1997-06-30 | Lynx Therapeutics | Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
US5599922A (en) * | 1994-03-18 | 1997-02-04 | Lynx Therapeutics, Inc. | Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties |
US5726297A (en) * | 1994-03-18 | 1998-03-10 | Lynx Therapeutics, Inc. | Oligodeoxyribonucleotide N3' P5' phosphoramidates |
US5399666A (en) * | 1994-04-21 | 1995-03-21 | E. I. Du Pont De Nemours And Company | Easily degradable star-block copolymers |
CA2188563C (en) | 1994-04-29 | 2005-08-02 | Andrew W. Buirge | Stent with collagen |
US5629077A (en) | 1994-06-27 | 1997-05-13 | Advanced Cardiovascular Systems, Inc. | Biodegradable mesh and film stent |
US5670558A (en) | 1994-07-07 | 1997-09-23 | Terumo Kabushiki Kaisha | Medical instruments that exhibit surface lubricity when wetted |
US5554120A (en) | 1994-07-25 | 1996-09-10 | Advanced Cardiovascular Systems, Inc. | Polymer blends for use in making medical devices including catheters and balloons for dilatation catheters |
US5817327A (en) * | 1994-07-27 | 1998-10-06 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5593403A (en) * | 1994-09-14 | 1997-01-14 | Scimed Life Systems Inc. | Method for modifying a stent in an implanted site |
US5578073A (en) | 1994-09-16 | 1996-11-26 | Ramot Of Tel Aviv University | Thromboresistant surface treatment for biomaterials |
US5649977A (en) | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
AU700903B2 (en) * | 1994-10-12 | 1999-01-14 | Focal, Inc. | Targeted delivery via biodegradable polymers |
US5765682A (en) | 1994-10-13 | 1998-06-16 | Menlo Care, Inc. | Restrictive package for expandable or shape memory medical devices and method of preventing premature change of same |
IL115755A0 (en) | 1994-10-27 | 1996-01-19 | Medinol Ltd | X-ray visible stent |
US5707385A (en) * | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
US5637113A (en) | 1994-12-13 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
US6017577A (en) | 1995-02-01 | 2000-01-25 | Schneider (Usa) Inc. | Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices |
US5919570A (en) | 1995-02-01 | 1999-07-06 | Schneider Inc. | Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices |
US5876743A (en) * | 1995-03-21 | 1999-03-02 | Den-Mat Corporation | Biocompatible adhesion in tissue repair |
US5605696A (en) * | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
JP2795824B2 (en) * | 1995-05-12 | 1998-09-10 | オオタ株式会社 | Surface treatment method for titanium-based implant and biocompatible titanium-based implant |
US5954744A (en) | 1995-06-06 | 1999-09-21 | Quanam Medical Corporation | Intravascular stent |
US5591199A (en) * | 1995-06-07 | 1997-01-07 | Porter; Christopher H. | Curable fiber composite stent and delivery system |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US5820917A (en) * | 1995-06-07 | 1998-10-13 | Medtronic, Inc. | Blood-contacting medical device and method |
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
US5667767A (en) | 1995-07-27 | 1997-09-16 | Micro Therapeutics, Inc. | Compositions for use in embolizing blood vessels |
GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
US5830879A (en) | 1995-10-02 | 1998-11-03 | St. Elizabeth's Medical Center Of Boston, Inc. | Treatment of vascular injury using vascular endothelial growth factor |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US5607442A (en) * | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
US6048964A (en) | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
ATE330644T1 (en) | 1995-12-18 | 2006-07-15 | Angiotech Biomaterials Corp | CROSS-LINKED POLYMER MATERIALS AND METHODS FOR USE THEREOF |
WO1997025002A1 (en) | 1996-01-05 | 1997-07-17 | Medtronic, Inc. | Expansible endoluminal prostheses |
US6150630A (en) | 1996-01-11 | 2000-11-21 | The Regents Of The University Of California | Laser machining of explosives |
WO1997027959A1 (en) | 1996-01-30 | 1997-08-07 | Medtronic, Inc. | Articles for and methods of making stents |
CN1213316A (en) | 1996-03-11 | 1999-04-07 | 富克尔公司 | Polymeric delivery of radionuclides and radiopharmaceuticals |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
US6071266A (en) | 1996-04-26 | 2000-06-06 | Kelley; Donald W. | Lubricious medical devices |
US6592617B2 (en) | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
US5914182A (en) | 1996-06-03 | 1999-06-22 | Gore Hybrid Technologies, Inc. | Materials and methods for the immobilization of bioactive species onto polymeric substrates |
US5874165A (en) * | 1996-06-03 | 1999-02-23 | Gore Enterprise Holdings, Inc. | Materials and method for the immobilization of bioactive species onto polymeric subtrates |
US5830178A (en) | 1996-10-11 | 1998-11-03 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide |
US5800516A (en) | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
US6344271B1 (en) | 1998-11-06 | 2002-02-05 | Nanoenergy Corporation | Materials and products using nanostructured non-stoichiometric substances |
US5855618A (en) * | 1996-09-13 | 1999-01-05 | Meadox Medicals, Inc. | Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6387121B1 (en) | 1996-10-21 | 2002-05-14 | Inflow Dynamics Inc. | Vascular and endoluminal stents with improved coatings |
US5868781A (en) * | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
US5833651A (en) | 1996-11-08 | 1998-11-10 | Medtronic, Inc. | Therapeutic intraluminal stents |
US5877263A (en) | 1996-11-25 | 1999-03-02 | Meadox Medicals, Inc. | Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents |
US5728751A (en) | 1996-11-25 | 1998-03-17 | Meadox Medicals, Inc. | Bonding bio-active materials to substrate surfaces |
US5741881A (en) | 1996-11-25 | 1998-04-21 | Meadox Medicals, Inc. | Process for preparing covalently bound-heparin containing polyurethane-peo-heparin coating compositions |
IT1289728B1 (en) | 1996-12-10 | 1998-10-16 | Sorin Biomedica Cardio Spa | SYSTEM AND EQUIPMENT DEVICE THAT INCLUDES IT |
US5980972A (en) | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
IT1291001B1 (en) | 1997-01-09 | 1998-12-14 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND ITS PRODUCTION PROCESS |
US5733330A (en) * | 1997-01-13 | 1998-03-31 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent |
US6159951A (en) | 1997-02-13 | 2000-12-12 | Ribozyme Pharmaceuticals Inc. | 2'-O-amino-containing nucleoside analogs and polynucleotides |
US6582472B2 (en) | 1997-02-26 | 2003-06-24 | Applied Medical Resources Corporation | Kinetic stent |
EP0975285B1 (en) | 1997-04-01 | 2008-10-01 | CAP Biotechnology, Inc. | Calcium phosphate microcarriers and microspheres |
US5874101A (en) * | 1997-04-14 | 1999-02-23 | Usbiomaterials Corp. | Bioactive-gel compositions and methods |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
FI103715B1 (en) | 1997-04-21 | 1999-08-31 | Heimo Ylaenen | New composite and its use |
US5879697A (en) * | 1997-04-30 | 1999-03-09 | Schneider Usa Inc | Drug-releasing coatings for medical devices |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US6303901B1 (en) | 1997-05-20 | 2001-10-16 | The Regents Of The University Of California | Method to reduce damage to backing plate |
US5891192A (en) | 1997-05-22 | 1999-04-06 | The Regents Of The University Of California | Ion-implanted protein-coated intralumenal implants |
US6056993A (en) | 1997-05-30 | 2000-05-02 | Schneider (Usa) Inc. | Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel |
DE19731021A1 (en) | 1997-07-18 | 1999-01-21 | Meyer Joerg | In vivo degradable metallic implant |
US5980928A (en) | 1997-07-29 | 1999-11-09 | Terry; Paul B. | Implant for preventing conjunctivitis in cattle |
US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US5980564A (en) | 1997-08-01 | 1999-11-09 | Schneider (Usa) Inc. | Bioabsorbable implantable endoprosthesis with reservoir |
US6121027A (en) | 1997-08-15 | 2000-09-19 | Surmodics, Inc. | Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups |
US6117979A (en) | 1997-08-18 | 2000-09-12 | Medtronic, Inc. | Process for making a bioprosthetic device and implants produced therefrom |
WO1999011202A1 (en) | 1997-09-05 | 1999-03-11 | Icet, Inc. | Biomimetic calcium phosphate implant coatings and methods for making the same |
US6284333B1 (en) | 1997-09-10 | 2001-09-04 | Scimed Life Systems, Inc. | Medical devices made from polymer blends containing low melting temperature liquid crystal polymers |
US6010445A (en) * | 1997-09-11 | 2000-01-04 | Implant Sciences Corporation | Radioactive medical device and process |
EP1030913A2 (en) | 1997-09-22 | 2000-08-30 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Nucleic acid catalysts with endonuclease activity |
ES2290995T3 (en) | 1997-09-24 | 2008-02-16 | Med Institute, Inc. | RADIALLY EXPANDABLE ENDOPROTESIS. |
US5976182A (en) | 1997-10-03 | 1999-11-02 | Advanced Cardiovascular Systems, Inc. | Balloon-expandable, crush-resistant locking stent and method of loading the same |
US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
DE59808721D1 (en) | 1997-11-24 | 2003-07-17 | Efmt Entwicklungs Und Forschun | METHOD FOR IMMOBILIZING MEDIATOR MOLECULES ON INORGANIC AND METAL IMPLANT MATERIALS |
US6093463A (en) | 1997-12-12 | 2000-07-25 | Intella Interventional Systems, Inc. | Medical devices made from improved polymer blends |
US5957975A (en) | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
US5986169A (en) | 1997-12-31 | 1999-11-16 | Biorthex Inc. | Porous nickel-titanium alloy article |
EP1045677A4 (en) * | 1998-01-06 | 2005-01-12 | Aderans Res Inst Inc | Bioabsorbable fibers and reinforced composites produced therefrom |
US6224626B1 (en) | 1998-02-17 | 2001-05-01 | Md3, Inc. | Ultra-thin expandable stent |
WO1999042147A1 (en) | 1998-02-23 | 1999-08-26 | Massachusetts Institute Of Technology | Biodegradable shape memory polymers |
ES2265186T3 (en) | 1998-02-23 | 2007-02-01 | Mnemoscience Gmbh | POLYMERS WITH FORM MEMORY. |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6110188A (en) | 1998-03-09 | 2000-08-29 | Corvascular, Inc. | Anastomosis method |
US6113629A (en) | 1998-05-01 | 2000-09-05 | Micrus Corporation | Hydrogel for the therapeutic treatment of aneurysms |
US6083258A (en) | 1998-05-28 | 2000-07-04 | Yadav; Jay S. | Locking stent |
DE19856983A1 (en) | 1998-06-25 | 1999-12-30 | Biotronik Mess & Therapieg | Implantable, bioresorbable vascular wall support, in particular coronary stent |
DE59913189D1 (en) | 1998-06-25 | 2006-05-04 | Biotronik Ag | Implantable, bioabsorbable vessel wall support, in particular coronary stent |
US6153252A (en) | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
CA2338788A1 (en) * | 1998-09-02 | 2000-03-09 | Scimed Life Systems, Inc. | Drug delivery device for stent |
ES2185227T3 (en) | 1998-10-19 | 2003-04-16 | Synthes Ag | CERAMIC HYDRAULIC CEMENT THAT TURNS. |
DE19855421C2 (en) | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implant |
CA2254002A1 (en) | 1998-11-12 | 2000-05-12 | Takiron Co., Ltd. | Shape-memory, biodegradable and absorbable material |
US6125523A (en) | 1998-11-20 | 2000-10-03 | Advanced Cardiovascular Systems, Inc. | Stent crimping tool and method of use |
US6350277B1 (en) | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
CA2360938C (en) | 1999-02-02 | 2008-01-08 | Warren Oliver Haggard | Controlled release composite |
US6187045B1 (en) | 1999-02-10 | 2001-02-13 | Thomas K. Fehring | Enhanced biocompatible implants and alloys |
US6183505B1 (en) * | 1999-03-11 | 2001-02-06 | Medtronic Ave, Inc. | Method of stent retention to a delivery catheter balloon-braided retainers |
US6066156A (en) | 1999-03-11 | 2000-05-23 | Advanced Cardiovascular Systems, Inc. | Temperature activated adhesive for releasably attaching stents to balloons |
US6667049B2 (en) | 1999-06-14 | 2003-12-23 | Ethicon, Inc. | Relic process for producing bioresorbable ceramic tissue scaffolds |
US6312459B1 (en) | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US6177523B1 (en) * | 1999-07-14 | 2001-01-23 | Cardiotech International, Inc. | Functionalized polyurethanes |
AUPQ170799A0 (en) | 1999-07-20 | 1999-08-12 | Cardiac Crc Nominees Pty Limited | Shape memory polyurethane or polyurethane-urea polymers |
US6569193B1 (en) | 1999-07-22 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Tapered self-expanding stent |
DE19938704C1 (en) | 1999-08-14 | 2001-10-31 | Ivoclar Vivadent Ag | Process for the production of reaction systems for implantation in the human and animal body as a bone substitute, which i.a. Contain calcium and phosphorus |
US6479565B1 (en) | 1999-08-16 | 2002-11-12 | Harold R. Stanley | Bioactive ceramic cement |
US6379381B1 (en) | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
JP4172883B2 (en) | 1999-09-08 | 2008-10-29 | Hoya株式会社 | Drug sustained release carrier and method for producing drug sustained release carrier |
WO2001026584A1 (en) | 1999-10-14 | 2001-04-19 | United Stenting, Inc. | Stents with multilayered struts |
DE19953771C1 (en) * | 1999-11-09 | 2001-06-13 | Coripharm Medizinprodukte Gmbh | Absorbable bone implant material and method for producing the same |
US6491666B1 (en) | 1999-11-17 | 2002-12-10 | Microchips, Inc. | Microfabricated devices for the delivery of molecules into a carrier fluid |
US7947069B2 (en) | 1999-11-24 | 2011-05-24 | University Of Washington | Medical devices comprising small fiber biomaterials, and methods of use |
US6554854B1 (en) | 1999-12-10 | 2003-04-29 | Scimed Life Systems, Inc. | Process for laser joining dissimilar metals and endoluminal stent with radiopaque marker produced thereby |
US6494908B1 (en) | 1999-12-22 | 2002-12-17 | Ethicon, Inc. | Removable stent for body lumens |
US6338739B1 (en) | 1999-12-22 | 2002-01-15 | Ethicon, Inc. | Biodegradable stent |
US6981987B2 (en) | 1999-12-22 | 2006-01-03 | Ethicon, Inc. | Removable stent for body lumens |
US6375826B1 (en) | 2000-02-14 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Electro-polishing fixture and electrolyte solution for polishing stents and method |
KR100371559B1 (en) | 2000-04-03 | 2003-02-06 | 주식회사 경원메디칼 | Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material |
US6527801B1 (en) * | 2000-04-13 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Biodegradable drug delivery material for stent |
EP1153621A1 (en) | 2000-05-12 | 2001-11-14 | MERCK PATENT GmbH | Biocements based on a mixture of TCP-PHA with improved compressive strength |
US6395326B1 (en) | 2000-05-31 | 2002-05-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for depositing a coating onto a surface of a prosthesis |
IL137090A (en) | 2000-06-29 | 2010-04-15 | Pentech Medical Devices Ltd | Polymeric stent |
US6569191B1 (en) | 2000-07-27 | 2003-05-27 | Bionx Implants, Inc. | Self-expanding stent with enhanced radial expansion and shape memory |
US6485512B1 (en) | 2000-09-27 | 2002-11-26 | Advanced Cardiovascular Systems, Inc. | Two-stage light curable stent and delivery system |
US6746773B2 (en) | 2000-09-29 | 2004-06-08 | Ethicon, Inc. | Coatings for medical devices |
US20020111590A1 (en) | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
US6492615B1 (en) | 2000-10-12 | 2002-12-10 | Scimed Life Systems, Inc. | Laser polishing of medical devices |
US6517888B1 (en) * | 2000-11-28 | 2003-02-11 | Scimed Life Systems, Inc. | Method for manufacturing a medical device having a coated portion by laser ablation |
US6664335B2 (en) | 2000-11-30 | 2003-12-16 | Cardiac Pacemakers, Inc. | Polyurethane elastomer article with “shape memory” and medical devices therefrom |
US6565599B1 (en) | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
US6540777B2 (en) | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
ATE376818T1 (en) | 2001-02-27 | 2007-11-15 | Igaki Iryo Sekkei Kk | STENT HOLDING ELEMENT AND STENT DELIVERY SYSTEM |
US6679980B1 (en) * | 2001-06-13 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Apparatus for electropolishing a stent |
US6695920B1 (en) * | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
WO2003026532A2 (en) | 2001-09-28 | 2003-04-03 | Boston Scientific Limited | Medical devices comprising nanomaterials and therapeutic methods utilizing the same |
US20030105530A1 (en) | 2001-12-04 | 2003-06-05 | Inion Ltd. | Biodegradable implant and method for manufacturing one |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
US20030187495A1 (en) | 2002-04-01 | 2003-10-02 | Cully Edward H. | Endoluminal devices, embolic filters, methods of manufacture and use |
US7270675B2 (en) | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
US20030236563A1 (en) | 2002-06-20 | 2003-12-25 | Dan Fifer | Stent delivery catheter with retention bands |
US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
US6818063B1 (en) | 2002-09-24 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for minimizing coating defects |
US7455687B2 (en) | 2002-12-30 | 2008-11-25 | Advanced Cardiovascular Systems, Inc. | Polymer link hybrid stent |
US20040143317A1 (en) | 2003-01-17 | 2004-07-22 | Stinson Jonathan S. | Medical devices |
US20040167610A1 (en) | 2003-02-26 | 2004-08-26 | Fleming James A. | Locking stent |
US6846323B2 (en) * | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20070135895A1 (en) | 2005-12-13 | 2007-06-14 | Robert Burgermeister | Polymeric stent having modified molecular structures in both the hoops and selected segments of the flexible connectors |
-
2006
- 2006-06-30 US US11/479,111 patent/US7740791B2/en not_active Expired - Fee Related
-
2007
- 2007-06-28 WO PCT/US2007/015242 patent/WO2008005390A1/en active Application Filing
-
2010
- 2010-06-15 US US12/816,275 patent/US20100256742A1/en not_active Abandoned
-
2014
- 2014-11-14 US US14/542,395 patent/US9808982B2/en not_active Expired - Fee Related
Patent Citations (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2922255A (en) * | 1956-03-22 | 1960-01-26 | Gen Electric | Mold apparatus for casting glass |
US3636956A (en) * | 1970-05-13 | 1972-01-25 | Ethicon Inc | Polylactide sutures |
US4547416A (en) * | 1980-11-19 | 1985-10-15 | Metal Box Limited | Thermoplastics articles and method and apparatus for making them |
US4957687A (en) * | 1983-11-07 | 1990-09-18 | Bulent Akman | Method for making profiled plastic tubes such as corrugated tubes |
US4987025A (en) * | 1985-08-12 | 1991-01-22 | Mitsui Petrochemical Industries, Ltd. | Inflation film of ultrahigh molecular weight polyethylene |
US4698196A (en) * | 1985-12-24 | 1987-10-06 | Xerox Corporation | Method and apparatus for extruding creaseless thin walled tubes |
US4702884A (en) * | 1986-07-03 | 1987-10-27 | The United States Of America As Represented By The Secretary Of The Navy | Glass-lined pipes |
US5147302A (en) * | 1989-04-21 | 1992-09-15 | Scimed Life Systems, Inc. | Method of shaping a balloon of a balloon catheter |
US5087394A (en) * | 1989-11-09 | 1992-02-11 | Scimed Life Systems, Inc. | Method for forming an inflatable balloon for use in a catheter |
US5108416A (en) * | 1990-02-13 | 1992-04-28 | C. R. Bard, Inc. | Stent introducer system |
US5116365A (en) * | 1991-02-22 | 1992-05-26 | Cordis Corporation | Stent apparatus and method for making |
US5500013A (en) * | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
US20020077592A1 (en) * | 1994-06-30 | 2002-06-20 | Boston Scientific Corporation | Replenishable stent and delivery system |
US5591230A (en) * | 1994-09-07 | 1997-01-07 | Global Therapeutics, Inc. | Radially expandable stent |
US5922005A (en) * | 1994-10-27 | 1999-07-13 | Medinol Ltd. | Stent fabrication method |
US5780807A (en) * | 1994-11-28 | 1998-07-14 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for direct laser cutting of metal stents |
US5628786A (en) * | 1995-05-12 | 1997-05-13 | Impra, Inc. | Radially expandable vascular graft with resistance to longitudinal compression and method of making same |
US5670161A (en) * | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US5906759A (en) * | 1996-12-26 | 1999-05-25 | Medinol Ltd. | Stent forming apparatus with stent deforming blades |
US5891386A (en) * | 1997-04-25 | 1999-04-06 | Medtronic, Inc. | Method for making catheter balloons |
US6645422B2 (en) * | 1997-05-14 | 2003-11-11 | Jomed, Inc. | Method for manufacturing a balloon for a dilation catheter |
US6626939B1 (en) * | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US20020151965A1 (en) * | 1998-05-29 | 2002-10-17 | Micro Therapeutics, Inc. | Rolled stent with waveform perforation pattern |
US7066952B2 (en) * | 1998-09-08 | 2006-06-27 | Kabushikikaisha Igaki Iryo Sekkei | Method for manufacturing yarn for vessel stent |
US20030055488A1 (en) * | 1998-09-08 | 2003-03-20 | Keiji Igaki | Method for manufacturing yarn for vessel stent |
US20010014821A1 (en) * | 1998-11-16 | 2001-08-16 | Mohamad Ike Juman | Balloon catheter and stent delivery system having enhanced stent retention |
US20020138133A1 (en) * | 1999-11-09 | 2002-09-26 | Scimed Life Systems, Inc. | Stent with variable properties |
US20030028246A1 (en) * | 1999-11-19 | 2003-02-06 | Palmaz Julio C. | Compliant implantable medical devices and methods of making same |
US6572813B1 (en) * | 2000-01-13 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Balloon forming process |
US7070615B1 (en) * | 2000-03-13 | 2006-07-04 | Keiji Igaki | Linear material for blood vessel stent and blood vessel stent utilizing same |
US6574851B1 (en) * | 2000-07-31 | 2003-06-10 | Advanced Cardiovascular Systems, Inc. | Stent made by rotational molding or centrifugal casting and method for making the same |
US20050033412A1 (en) * | 2000-09-28 | 2005-02-10 | Wu Steven Z. | Method of making an implantable medical device |
US20030187158A1 (en) * | 2000-11-30 | 2003-10-02 | The Procter & Gamble Company | High molecular weight polyolefin and catalyst and process for polymerising said polyolefin |
US20030226833A1 (en) * | 2001-02-15 | 2003-12-11 | Scimed Life Systems, Inc. | Laser cutting of stents and other medical devices |
US20040191404A1 (en) * | 2001-04-12 | 2004-09-30 | Syed Hossainy | Method of making a variable surface area stent |
US20050004663A1 (en) * | 2001-05-07 | 2005-01-06 | Llanos Gerard H. | Heparin barrier coating for controlled drug release |
US6521865B1 (en) * | 2001-06-14 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Pulsed fiber laser cutting system for medical implants |
US20030028241A1 (en) * | 2001-08-02 | 2003-02-06 | Stinson Jonathan Swift | Method for enhancing sheet or tubing metal stent radiopacity |
US7083639B2 (en) * | 2001-09-26 | 2006-08-01 | Medtronic Vascular, Inc. | Stent delivery catheter with grooved balloon and methods of making same |
US20030083732A1 (en) * | 2001-10-25 | 2003-05-01 | Stinson Jonathan S. | Balloon expandable polymer stent with reduced elastic recoil |
US20040199242A1 (en) * | 2001-12-27 | 2004-10-07 | James Hong | Hybrid intravascular stent |
US6866805B2 (en) * | 2001-12-27 | 2005-03-15 | Advanced Cardiovascular Systems, Inc. | Hybrid intravascular stent |
US20030208254A1 (en) * | 2002-05-03 | 2003-11-06 | James Shortt | Method and apparatus for mounting a stent onto a stent delivery system |
US20040000361A1 (en) * | 2002-06-27 | 2004-01-01 | Thomas Trozera | Method of manufacturing an implantable stent having improved mechanical properties |
US20040098090A1 (en) * | 2002-11-14 | 2004-05-20 | Williams Michael S. | Polymeric endoprosthesis and method of manufacture |
US7128868B2 (en) * | 2003-01-10 | 2006-10-31 | Boston Scientific Scimed, Inc. | Balloon wing forming apparatus and method |
US20050137678A1 (en) * | 2003-12-22 | 2005-06-23 | Medtronic Vascular, Inc. | Low profile resorbable stent |
US20050146085A1 (en) * | 2004-01-07 | 2005-07-07 | Scimed Life Systems, Inc. | Process and apparatus for forming medical device balloons |
US20050196485A1 (en) * | 2004-01-13 | 2005-09-08 | Martin Cass | Heat transfer system for a mold |
US20050177130A1 (en) * | 2004-02-10 | 2005-08-11 | Angioscore, Inc. | Balloon catheter with spiral folds |
US20050187615A1 (en) * | 2004-02-23 | 2005-08-25 | Williams Michael S. | Polymeric endoprostheses with enhanced strength and flexibility and methods of manufacture |
US20090012598A1 (en) * | 2004-06-29 | 2009-01-08 | Abbate Anthony J | Method of fabricating an implantable medical device by deformation of a tube or a sheet |
US20060020330A1 (en) * | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US7306585B2 (en) * | 2004-09-30 | 2007-12-11 | Engineering Resources Group, Inc. | Guide catheter |
US20060076708A1 (en) * | 2004-09-30 | 2006-04-13 | Bin Huang | Method of fabricating a biaxially oriented implantable medical device |
US20060211952A1 (en) * | 2005-03-18 | 2006-09-21 | Wilson-Cook Medical Inc. | Wire guides having novel outer surface areas and reservoirs for enhancing hydrophilic properties and delivering therapeutic agents |
US20060224226A1 (en) * | 2005-03-31 | 2006-10-05 | Bin Huang | In-vivo radial orientation of a polymeric implantable medical device |
US7381048B2 (en) * | 2005-04-12 | 2008-06-03 | Advanced Cardiovascular Systems, Inc. | Stents with profiles for gripping a balloon catheter and molds for fabricating stents |
US20060229695A1 (en) * | 2005-04-12 | 2006-10-12 | Brown Daniel G | Stents with profiles for gripping a balloon catheter and molds for fabricating stents |
US7476245B2 (en) * | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US20070253999A1 (en) * | 2006-04-28 | 2007-11-01 | Bin Huang | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US20070253996A1 (en) * | 2006-04-28 | 2007-11-01 | Huang Bin | Method of fabricating an implantable medical device by controlling crystalline structure |
US20070282433A1 (en) * | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US20070293938A1 (en) * | 2006-06-15 | 2007-12-20 | Gale David C | Methods of fabricating stents with enhanced fracture toughness |
US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US20090005860A1 (en) * | 2007-06-27 | 2009-01-01 | Gale David C | Method to fabricate a stent having selected morphology to reduce restenosis |
US20090001633A1 (en) * | 2007-06-29 | 2009-01-01 | Limon Timothy A | Method Of Manufacturing A Stent From A Polymer Tube |
US20090146348A1 (en) * | 2007-12-11 | 2009-06-11 | Bin Huang | Method of fabrication a stent from blow molded tubing |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110277305A1 (en) * | 2007-05-04 | 2011-11-17 | Abbott Cardiovascular Systems Inc. | Stents with high radial strength and methods of manufacturing same |
US9198785B2 (en) | 2010-01-30 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US9867728B2 (en) | 2010-01-30 | 2018-01-16 | Abbott Cardiovascular Systems Inc. | Method of making a stent |
US11324614B2 (en) | 2010-01-30 | 2022-05-10 | Abbott Cardiovascular Systems Inc. | Balloon expanded polymer stent |
US9827119B2 (en) | 2010-01-30 | 2017-11-28 | Abbott Cardiovascular Systems Inc. | Polymer scaffolds having a low crossing profile |
US9770351B2 (en) | 2010-01-30 | 2017-09-26 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US9763818B2 (en) | 2010-01-30 | 2017-09-19 | Abbott Cardiovascular Systems Inc. | Method of crimping stent on catheter delivery assembly |
US10123894B2 (en) | 2010-01-30 | 2018-11-13 | Abbott Cardiovascular Systems Inc. | Method of crimping stent on catheter delivery assembly |
US20110282428A1 (en) * | 2010-05-13 | 2011-11-17 | Boston Scientific Scimed, Inc. | Biodegradable composite stent |
US9038514B2 (en) * | 2010-07-14 | 2015-05-26 | Atex Technologies, Inc. | Fabric cutting system and method |
US10610969B2 (en) | 2010-07-14 | 2020-04-07 | Atex Technologies Inc. | Fabric cutting system and method |
US20130338432A1 (en) * | 2010-07-14 | 2013-12-19 | Atex Technologies, Inc. | Fabric Cutting System and Method |
US8540619B2 (en) * | 2010-07-14 | 2013-09-24 | Atex Technologies, Inc. | Fabric cutting system and method |
US20120012569A1 (en) * | 2010-07-14 | 2012-01-19 | Danny Severino | Fabric cutting system and method |
US20120280432A1 (en) * | 2011-05-06 | 2012-11-08 | Industrial Technology Research Institute | Method for manufacturing bioabsorbable stents |
US10307274B2 (en) | 2011-07-29 | 2019-06-04 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
WO2013053179A1 (en) * | 2011-10-14 | 2013-04-18 | 上海微创医疗器械(集团)有限公司 | Processing method for new biodegradable support |
CN105500673A (en) * | 2011-10-14 | 2016-04-20 | 上海微创医疗器械(集团)有限公司 | Novel machining method of biodegradable stent |
CN102371670A (en) * | 2011-10-14 | 2012-03-14 | 微创医疗器械(上海)有限公司 | New processing method of biodegradable stent |
US10117761B2 (en) | 2014-12-19 | 2018-11-06 | Boston Scientific Scimed, Inc. | Stent with anti-migration features |
WO2016100789A1 (en) * | 2014-12-19 | 2016-06-23 | Boston Scientific Scimed, Inc. | Stent with anti-migration features |
Also Published As
Publication number | Publication date |
---|---|
WO2008005390A1 (en) | 2008-01-10 |
US7740791B2 (en) | 2010-06-22 |
US20160046058A1 (en) | 2016-02-18 |
US20080001333A1 (en) | 2008-01-03 |
US9808982B2 (en) | 2017-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9808982B2 (en) | Tapered polymeric stent and method of fabricating same | |
US10390979B2 (en) | Manufacturing process for polymeric stents | |
US7875233B2 (en) | Method of fabricating a biaxially oriented implantable medical device | |
EP1773566B1 (en) | Method of fabricating an implantable medical device with biaxially oriented polymers | |
US7731890B2 (en) | Methods of fabricating stents with enhanced fracture toughness | |
US8043553B1 (en) | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article | |
US20090012598A1 (en) | Method of fabricating an implantable medical device by deformation of a tube or a sheet | |
US10058439B2 (en) | Deformation of a polymer tube in the fabrication of a medical article | |
EP2046411A1 (en) | Fabricating a stent with selected properties in the radial and axial directions | |
US8173062B1 (en) | Controlled deformation of a polymer tube in fabricating a medical article | |
US8241554B1 (en) | Method of forming a stent pattern on a tube |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |